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Å    Angstrom (1 Å = 0.1 nm = 10-10 m) 
AA   Amino acid 
CBD   Chitin-binding domain 
CBR   C-terminus binding region 
CHAPS  3-[(3-Cholamidopropyl)-dimethylammonio]-propansulfonat 
CHM   Choroideremia 
Cmc   Critical micelle concentration 
CTAB   Cetyltrimethylammoniumbromide 
Da    Dalton 
Dans / Dansyl 5-Dimethylaminonaphtalin-1-sulfonyl 
DDMAB  N-Dodecyl-N,N-(dimethylammonio)butyrate 
DTE   1,4-Dithioerythritol 
EPL   Expressed protein ligation 
FTase   Farnesyltransferase 
FRET   Fluorescence resonance energy transfer 
GAP   GTPase activating protein 
GDF   GDI displacement factor 
GDI   GDP dissociation inhibitor 
GdmHCl  Guanidinium hydrochloride 
GEF   Guaninenucleotide exchange factor 
GF   Gel filtration 
GG   Geranylgeranyl 
GGPP  Geranylgeranylpyrophosphate 
GGTase  Geranylgeranyltransferase 
GST   Glutathione S-transferase 
GTPase  Guaninetriphosphate phosphatase 
HPLC   High performance liquid chromatography 
HOPS   Homotypic fusion and vacuole protein sorting 
Hsp   Heat shock protein 
IPTG   Isopropyl-β-D-thiogalactoside 
LC-MS  Liquid chromatography-mass spectrometry 
LDAO   Lauryldimethylamine-N-Oxid 
MALDI-TOF-MS Matrix assisted laser desorption/ionization-time of flight  
   mass spectrometry 
MEL   Mobile effector loop 
MetAP  Methionylaminopeptidase 
MWCO  Molecular weight cut off 
NBD   7-Nitrobenz-2-oxa-1,3-diazol-4-yl 
NCL   Native chemical ligation 
NSF   N-ethyl-maleimide sensitive fusion protein 
OD600   Optical density at 600 nm  
Rab   Ras-like (protein) from Rat brain 
Ras   Rat adeno sarcoma 
REP   Rab escort protein 
RP-HPLC  Reversed-phase high performance liquid chromatography 
RRF   Rab recyling factor 
RT   Room temperature 
SDS   Sodium dodecyl sulfate 
Sec   Secretory protein 
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SNAP   Soluble NSF attachment protein 
SNARE  Soluble NSF attachment protein receptor 
SPPS   Solid phase peptide synthesis 
StBu   S-tert-butyl 
TEV   Tobacco Etch Virus 
TFA   Trifluoroacetic acid 
TK   Krafft point 
TX-100/TX-114 Triton X-100/Triton X-114 
VAMP   Vesicle associated membrane protein 
Xaa/Yaa  designates any amino acid residue 
Yip   Ypt-interacting protein 
Ypt   Yeast protein transport 
 
One- and three-letter abbreviations for amino acids were used according to the 
recommendations of the International Union of Pure and Applied Chemistry (IUPAC) 
and the International Union of Biochemistry (IUB).[1] 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
 
 
 
 
 
“Things should be made as simple as possible, 
but not any simpler.” 
 
Albert Einstein
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1. Introduction 
1.1. Vesicular Transport 
 
Controlled fusion and fission of biological membranes is essential for all forms of life. 
Eukaryotes in particular, due to a high degree of compartmentation, subcellular 
specialization and differentiation, require sophisticated mechanisms that ensure 
regulated and specific membrane turnover. Within cells, exo- and endocytosis as well 
as transfer between subcellular compartments are mediated by vesicular transport. 
Vesicle formation (budding), targeting to the destination membrane and fusion are 
controlled by a large number of proteins conserved throughout evolution.  
Central to vesicle fusion is the mutual recognition of vesicular v-SNAREs and target 
t-SNAREs, forming very stable four-helical coiled-coil bundles (see Figure 1-1 inset)*. 
The initial priming stage involves the disruption of cis-SNARE complexes 
(i.e. complexes formed between SNAREs located on the same membrane) by the 
ATPase NSF (N-ethyl-maleimide sensitive fusion protein) and its cochaperone 
α-SNAP.[4] The activated SNAREs are then competent to form trans-SNARE 
complexes, resulting in a positioning of the vesicle in close proximity to the target 
membrane (docking). The progressive zipping of trans-SNARE complexes is finally 
believed to exert a mechanical force on the membranes via their transmembrane 
regions, resulting in pore formation and mixing of luminal contents.[5] Although 
purified SNAREs reconstituted into separate liposomes can alone mediate a fusion 
reaction on the order of minutes,[6] physiological fusion reactions, which often happen 
in the microsecond range, require additional accelerating factors. These probably 
include Ca2+ sensing proteins and associated factors (calmodulin, synaptotagmins, 
protein phosphatase 1) that trigger membrane fusion upon localized transient Ca2+ 
fluxes preceding every fusion reaction.[7,8] Studies of yeast homotypic vacuolar fusion 
recently identified the V0 part of the vacuolar ATPase to be activated by 
Ca2+/Calmodulin and demonstrate formation of trans-V0 channels between the 
docked membranes.[9] Speculations that these protein channels radially expand and 
become the initial fusion pore are highly controversial, but could explain many 
observations from different fusion systems (discussed in [10,11]).  
                                                 
* A new nomenclature classifies SNAREs according to invariant arginine (R) or glutamine residues (Q) 
present in the SNARE binding domains, which form the four helix bundle.[2,3] 
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The mostly unique intracellular localizations of SNARE family members and their 
specific interactions led to the formulation of the SNARE hypothesis,[12,13] that the 
formation of specific SNARE complexes between SNARE partners associated with 
the same transport step mediates vesicle docking at the correct target membrane. It 
now appears however, that SNARE pairing is rather promiscuous and that additional 
components have to ensure specificity by adding an extra layer of control.[14-17]  
 
 
 
 
 
Figure 1-1: Vesicule fusion with target membranes can be biochemically dissected into 4 steps. 
Priming: The ATP-driven disruption of cis-SNARE complexes by NSF and α-SNAP. Tethering: Weak 
association between large tethering complexes mediated by Rab proteins. Docking: Strong 
association between v- and t-SNAREs leading to trans-SNARE pairing, initiated by Rab proteins. 
Fusion: membrane fusion triggered by zippering of SNAREs and associated regulatory proteins. 
Inset: A structural view on trans-SNARE pairing. Synaptobrevin 2 (VAMP-2, red, v/R-SNARE), 
Syntaxin 1A (blue, t/Q-SNARE) and SNAP-25A (green, t/Q-SNARE) form a four helical coiled-coil 
bundle (SNARE complex). Transmembrane and linker regions are drawn schematically. 
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1.1.1. Rab proteins 
 
Rab proteins are small Ras-related GTP-binding proteins that are believed to be key 
regulators of vesicular transport. With more than 60 members identified in 
mammalian cells and 11 members in yeast (termed Ypt proteins and Sec4p) they 
form the largest group of the Ras superfamily.[18] Apparently, the increased 
complexity of vesicular transport routes inside mammalian cell types compared to 
lower eukaryotes resulted in a significant expansion of the Rab family.[19] Indeed, 
certain Rab proteins could be assigned to distinct compartments and transport steps 
present in all eukaryotes, whereas other Rab isoforms were found to participate in 
specialized fusion processes in differentiated cells. The number of rab proteins in the 
eukaryotic cell is dwarfed by the number of rab interacting proteins, reflecting the 
complexity of Rab controlled networks (for review see [20]). For example, more than 
20 proteins were shown to be bound to Rab5 in its GTP bound form.[21] 
As for other GTPases, central to Rab functioning is their ability to cycle between 
active GTP- and inactive GDP-bound conformations, thereby acting as molecular 
‘on/off’ switches. In the active conformation Rab proteins recruit Rab effectors, a 
heterogeneous group of proteins, which exert various functions during vesicular 
transport. Rabs are converted into the inactive conformation by GTP hydrolysis, that 
leads to effector dissociation and Rab extraction from the membrane. The Rab 
protein is then recycled back to the donor compartment and reactivated by exchange 
of GDP for GTP. The combined cycles, i.e. GTP/GDP cycling and membrane 
association/cytosolic localization, are known as the Rab cycle, which is shown in 
Figure 1-2.  
Several recent studies suggest a role of rab proteins and their effectors in vesicle 
formation.[22] For example, the mannose-6-phosphate receptor (MPR), which 
sequesters cargo proteins into budding clathrin-coated vesicles, was shown to bind 
indirectly to Rab9-GTP via its effector TIP47 (tail interacting protein of 47 kDa). It 
seems reasonable that the endosome specific Rab protein triggers the recruitment of 
TIP47 to MPRs in a organelle specific manner resulting in specific and efficient MPR 
recycling.[23] Besides assisting cargo incorporation into budding vesicles (see 
also [24]), Rabs might additionally define the destination of the budding vesicle by 
recruiting proteins necessary for subsequent docking and fusion steps.[25]  
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Figure 1-2: The Rab cycle. See text for a detailed description. E = effector, TC = tethering complex, 
GAP = GTPase activating protein, RRF = Rab recycling factor, GDI = GDP dissociation inhibitor, 
GDF = GDI displacement factor, GEF = guaninenucleotide exchange factor. 
 
Following vesicle formation, at least some Rabs link transport vesicles to the 
cytoskeleton via kinesin/dynein-like motor-proteins, which confer actively directed 
vesicle movement along these structures.[26,27] Rab6 has been shown to interact 
directly with a kinesin-like effector protein, termed Rabkinesin-6, which probably acts 
as a microtubule plus-end directed motor and has been implicated in cytokinesis 
during mitosis.[28,29] Another well studied example involves the interaction of Rab27a 
with Myosin Va via melanophilin, the potential Rab27a effector.[30] Myosin Va is 
believed to tether melanosomes to the actin cytoskeleton, which actively retains 
these organelles near the cell peripherie of melanocytes, where they are eventually 
transferred to keratinocytes for proper skin and hair pigmentation.[31,32] This model is 
supported by several mutations in Rab27a[33] and Myosin Va[34] that lead to Griscelli 
Syndrome, a rare inherited disorder of pigmentation arising from the arrest and the 
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accumulation of melanosomes in the perinuclear region of melanocytes,  that is 
accompanied by severe immunological or neurological defects (see [35] for review).  
When the transport vesicle approaches its target membrane (Figure 1-2, step 3), Rab 
proteins initiate the assembly of tethering complexes by interacting with soluble 
effector proteins.[36,37] Tethering effectors fall into two main classes: A group of 
proteins forming extended homodimeric coiled-coil structures (e.g. EEA1, Uso1p, 
p115) and oligomeric complexes (e.g. HOPS, Exocyst, TRAPP and 
COG-complexes).[38,39] Although the details of their functioning remains elusive, most 
of them could be assigned to a distinct transport step and were shown to bind to 
Rabs and membranes.[40,41] Apparently, tethering complexes and Rabs precede 
trans-SNARE pairing representing the first specificity determinant during vesicle 
fusion. Moreover, Rabs and the tethering complexes might either directly or indirectly 
trigger SNARE pairing and subsequent fusion, as can be inferred from their 
numerous interactions with components of the SNARE fusion machinery (e.g. with 
NSF,[42] Sec1-like proteins,[43] or SNAREs directly,[44-46] discussed in [47]).  
Rab GTP hydrolysis is not obligatory for fusion,[48,49] rather the rate of nucleotide 
hydrolysis seems to define the timeframe for rab effector recruitment and therefore 
influences the progression of tethering, docking and fusion steps (but see also [50] for 
an alternative model). Hence, the steady-state level of activated Rab-GTP regulates 
the extent of fusion reactions and is, not surprisingly, highly regulated by additional 
factors. For example some of the above mentioned tethering complexes were shown 
to preserve the GTP bound state, thereby locking Rabs in the activated state by 
either promoting GDP to GTP exchange[51] or inhibiting GTPase activating protein 
(GAP) induced GTPase activity.[52] Following fusion, Rab proteins are inactivated by 
GTP hydrolysis stimulated by GAPs, which converts them back to their GDP bound 
form (see [53] for a review of this class of proteins).[54,55] Rab-GDP is targeted by Rab 
GDP-dissociation inhibitor (RabGDI), which upon binding inhibits Rab reactivation[56] 
and extracts them from the membrane into the cytosol.[57] It is likely that this step is 
mediated by additional factors, termed Rab recycling factors (RRFs).[58] One potential 
RRF candidate essential for Rab3A membrane extraction at the synapse was 
recently identified as a heat shock protein (Hsp) complex, consisting of Hsp90, Hsc70 
and cysteine string protein (CSP).[59] RabGDI delivers Rab proteins back to the donor 
membrane, consequently ensuring efficient Rab recycling.[60,61] The delivery process 
(Figure 1-2, step 7) probably involves proteins termed GDI displacement factors 
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(GDFs), that serve as the membrane receptor for Rabs and are believed to be key for 
the Rab compartment specific localisation.[62] Although the above mentioned Hsp 
complex might potentially also serve as a GDF,[59] the precise identity of GDFs has 
remained elusive, hindering a deeper understanding of the process. Recently, human 
Yip3p (PRA-1) was shown to catalytically displace RabGDI and to specifically recruit 
endosomal Rabs to reconstituted liposomes.[63] Yeast Yip (Ypt-interacting protein) 
family members (analogs exist in mammals, termed prenylated Rab acceptor (PRA)) 
were initially identified as proteins that can interact with Rabs in either their GDP or 
GTP bound state[64] and with each other,[65,66] and some members were found to be 
essential for yeast viability and vesicular transport.[67] Although the assigned GDF 
activity offers an interesting model for Yip mediated Rab recruitment, additional 
interactions with other components of the fusion machinery (e.g. with SNAREs[64] and 
vesicle coat proteins[68]) suggest a broader role for Yips in vesicular transport, which 
needs to be adressed.[69] Upon membrane binding, Rabs are converted to the active 
form by GDP to GTP exchange mediated by guanine nucleotide exchange factors 
(GEF) and the cycle starts again.[60,61] Interestingly, Rab activation seems often to be 
spatially and temporally restricted to the site of function, which is supported by the 
finding that numerous GEFs are in fact members of large protein complexes, that act 
also as rab effectors.[70,71] 
1.1.2. The structural basis of Rab function 
 
Rab GTPases contain conserved sequence elements that mediate GDP/GTP 
binding, effector recognition and subcellular localization. Although distantly related to 
Ras and other small GTPases  (< 30 % amino acid overall identity), they share short 
highly conserved motifs, termed PM and G motifs, which participate in 
phosphate/magnesium and guanine base binding, respectively (see 
Figure 1-3B,C).[72] The Rab structural fold is similar to all small GTPases of the Ras 
superfamily (also referred to as the GTPase-fold) consisting of a six stranded beta 
sheet surrounded by five alpha helices.[73,74] Conformational changes accompanying 
GTP to GDP hydrolysis and γ-phosphate release, as originally observed in Ras,[75,76] 
were also recently confirmed for Rab proteins,[77-79] although significant variations 
exist, which might explain differences in the rates of GTP hydrolysis and GDP 
exchange. These regions of major conformational changes, were termed switch I and 
switch II and form the β, γ-phosphate-magnesium ion binding pocket together with 
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the so called P-loop (Figure 1-3A). As mentioned above, key to Rab functioning is 
their participation in numerous interactions with upstream regulators and downstream 
effector molecules. The interacting proteins were proposed to recognize the correct 
nucleotide bound state by binding to switch I (also known as effector domain) and 
switch II regions based on genetic and functional studies employing mutant chimeric 
Rab proteins.[80,81] Further extensive sequence analysis studies revealed the 
presence of five Rab family motifs (RabF1-5) and four Rab subfamily motifs 
(RabSF1-4), that localize mainly around switch I and II and are conserved among 
different species (Figure 1-3B-D).[18,82] RabF motifs can be used for unambiguous 
identification of Rab proteins, whereas RabSF motifs determine the relatedness to 
one of the ten Rab subfamilies.  
 
 
 
Figure 1-3: Structural features of Rab proteins. A) Ribbon representation of Rab3 (PDB entry code 
3RAB) complexed with GppNHp (colored orange).[73] Switch I (yellow), Switch II (blue) and the P-Loop 
are indicated. B) Location of PM and G motifs (green), Rab family motifs (F, red) and Rab subfamily 
motifs (SF, blue). C) Surface representation of B. D) Organization of the identified motifs along the 
primary sequence. CC represents the prenylation motif.  
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Concerning the binding of interacting proteins, RabF motifs were proposed to be 
mainly recognized by general Rab regulators (such as GDI and REP, see below), 
whereas specific interactions with a certain subset of Rabs additionally require 
RabSF regions (e.g. most Rab-effector interactions and to some extent GEFs and 
GAPs). Confirmation of this model comes from several mutagenesis studies (e.g. [83]) 
and the structure of Rab3a complexed to the effector domain of Rabphilin-3A.[84] 
Although several Rabs are now structurally characterized,[85-88] this remains the only 
known Rab:effector structure. Given the numerous interactions Rabs participate in, 
the lack of structural information is striking. Another important structural feature of 
Rab proteins was identified by Chavrier et al.[89,90] and termed hypervariable region 
which comprises ca. 30 amino acid residues in the C-terminal region (Figure 1-3D). 
This region is presumed to serve as a targeting signal for the subcellular localization 
of Rab proteins and is at least in some cases subject to additional regulation. For 
example, phosphorylation within the hypervariable region of Rab4 during mitosis was 
shown to prevent membrane recruitment leading to accumulation of Rab4 in the 
cytosol.[91,92]  
Adjacent to the hypervariable region, directly at or near the C-terminus, hydrophobic 
geranylgeranyl isoprenoids are post-translationally attached to conserved cysteine 
residues.[93] This modification mediates the reversible attachement of Rab proteins to 
membranes and is essential for proper Rab functioning.[94]  
1.1.3. Rab geranylgeranylation 
 
Geranylgeranylation of Rab proteins is a posttranslational process catalyzed by 
Geranylgeranyltransferase type II (GGTase-II or RabGGTase), which transfers 
geranylgeranyl moieties from geranylgeranylpyrophosphate (GGPP) to C-terminal 
cysteine residues linking them via stable thioether bonds (Figure 1-4A).[95] GGTase-II 
belongs to the family of protein prenyltransferases together with Farnesyltransferase 
(FTase) and GGTase-I, which act on Ras and Rac/Rho GTPases, respectively.[96] 
FTase and GGTase-I are also known as CaaX prenyltransferases. The term refers to 
the short C-terminal substrate sequences recognized by both enzymes, where ‘C’ 
stands for the cysteine which is to be modified, ‘a’ designates an aliphatic residue 
and the identity of ‘X’ determines whether ‘C’ will be farnesylated by FTase 
(X = Ala, Gln, Met, Ser) or geranylgeranylated by GGTase-I (X = Leu).[95,97,98] In 
contrast, Rab prenylation motifs are more heterogenic including terminal CXC, CC, 
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CCX, CCXX and CCXXX sequences,[99,100] where both cysteines are modified by 
GGTase-II.[101] Rabs terminating with CXC sequences are additionally methyl 
esterified by an S-adenosyl-L-methionine (SAM) dependant enzyme activity following 
the prenylation reaction.[102-104] 
  
 
Figure 1-4: GGTase-II catalyzed geranylgeranylation of Rab proteins. A) Simplified reaction scheme 
(classical pathway). Rab-GDP, REP-1 and GGTase-II form a ternary complex. Prenyl groups are 
transferred in two consecutive reactions from GGPP to Rab. Another molecule of GGPP dissociates 
the double prenylated ternary complex (not shown) and Rab is delivered to membranes by the action 
of REP. B) Structure of the complex between GGTase-II (α and β subunit are colored red and blue, 
respectively. PDB entry code 1LTX), REP-1 (grey) and farnesylphosphonylmethylphosphonate (FPCP, 
analog of farnesylpyrophosphate, green).[105] REP can associate with GGTase-II in a isoprenoid 
pyrophosphate dependant manner without prior binding to Rab (alternative pathway).[106] 
      
GGTase-II consists of two subunits (α and β) forming a heterodimer of ca. 100 kDa 
that requires Zn2+ and Mg2+ for activity (Figure 1-4B).[107,108] In contrast to the other 
prenyltransferases, GGTase-II additionally requires a protein cofactor, originally 
termed component A, that was later identified as the product of the choroideremia 
(CHM) gene and eventually renamed as rab escort protein (REP).[107,109,110] REP 
associates with the unprenylated Rab protein preferentially in its GDP bound 
form[111-113] and facilitates its recognition by the catalytic GGTase α/β-heterodimer 
(Figure 1-4A).[110,114,115] Upon ternary complex formation, GGTase-II transfers both 
isoprenoids in two independent, consecutive reactions, with the monoprenylated 
intermediate being strongly bound to the enzyme.[116,117] Following double 
prenylation, binding of another GGPP molecule triggers release of the prenylated 
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Rab:REP complex[118] and Rab is delivered to the membrane with assistance of 
REP.[119] Two ubiquitiously expressed isoforms of REP have been identified in 
mammalian cells (REP-1 and REP-2),[120] whereas only a single protein mediates 
Rab prenylation in yeast (named Mrs6p or Msi4p).[121] Loss of REP-1 function has 
been linked to choroideremia (CHM), an X-linked inherited disease characterized by 
progressive retinal degeneration leading to complete blindness in adults.[109,122] The 
molecular mechanism underlying CHM was proposed to involve inefficient 
prenylation of certain Rabs due to malfunctioning of REP-1, which cannot be 
compensated by the REP-2 isoform. Although, Rab27a was found to accumulate 
unprenylated in CHM cells,[123] its role in CHM is under intensive debate.[124] For 
example Rab27a is widely expressed in several tissues unaffected in CHM patients, 
and its malfunction has been convincingly linked to Griscelli syndrome (see above) 
giving rise to symptoms not observed in CHM patients. 
Interestingly, REP and RabGDI (see above) share  approximately 30 % sequence 
identity and are structurally and functionally related.[105,109] Both proteins form the 
RabGDI/CHM family,[125] can bind prenylated Rabs preferentially in their GDP bound 
state, inhibit GDP release from the GTPase domain and can deliver the Rab proteins 
to their proper membrane site. However, RabGDI cannot replace REP in the 
prenylation reaction due to its low affinity for unprenylated Rabs,[126] whereas REP 
cannot functionally replace RabGDI´s ability to extract Rab proteins from 
membranes. Consequently both proteins are not functionally interchangeable as was 
demonstrated by complementation experiments performed in yeast.[121,127]   
In summary, geranylgeranylation is believed to be crucial for the proper functioning of 
all Rab proteins. On a molecular level the role of the lipids seems to be at least two-
fold: First, the geranylgeranyl groups are integral components of Rab interactions 
with other regulatory proteins. Currently several factors are known, that require 
prenylation for productive binding to Rab proteins: RabGDI,[126] several members of 
the Yip family[65,128] (including PRA-1[64,129]), Rab3-GAP[130] and Rab3-GEF.[131]  
Secondly, the hydrophobic isoprenoids mediate the essential membrane attachment 
of Rab proteins, probably by inserting into the lipid bilayer. Unprenylated Rabs cannot 
associate with membranes and are intracellularly restricted to the cytosol where they 
cannot fulfill their biological role. It is noteworthy, that the precise role of the lipid and 
the prenylation motif in Rab membrane targeting (beside the hypervariable region) is 
controversial: Recent studies suggest that double prenylation is required for correct 
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localization of Rab proteins to their characteristic subcellular target membrane, 
whereas single prenylated Rabs are mistargeted and appeared to be 
nonfunctional.[132,133] In contrast, Overmeyer et al. reported correct targeting of single 
prenylated Rab1.[134] Moreover, complete replacement of the prenylation motif by a 
transmembrane helix was found not to impair vesicular transport.[135] A consistent 
explanation of these findings is hindered by the complicated in vivo situation 
associated with GGTase-I and -II mediated prenylation reactions and the potentially 
pleiotropic effects of the significant structural modifications of the GTPase that were 
used to study these processes.  
On the other hand, many in vitro studies of Rab proteins are dependent on the 
availability of the posttranslationally modified form. In order to obtain prenylated 
Rabs, these are traditionally expressed and purified from animal tissues or from 
insect cell cultures infected with recombinant baculovirus. These methods generally 
suffer from low yields and inflexibility regarding the lipid modification. Both 
disadvantages could be bypassed by an alternative approach, which makes use of 
chemical protein synthesis instead of utilizing the often rigid and limiting cellular 
machinery. 
1.2. Chemical protein synthesis 
 
The idea of producing and engineering proteins via total synthesis continues to 
attract considerable attention since the development of solid-phase peptide synthesis 
(SPPS) by Merrifield.[136] The advantage of varying the covalent (primary) structure of 
proteins without limitations is generally believed to facilitate a better understanding of 
structure-function relationships. 
Indeed, Merrifield´s stepwise SPPS was used to assemble ribonuclease A,[137] growth 
factors (e.g. [138]) and HIV-1 protease.[139] In the case of HIV-1 protease, further 
studies enabled important insights into the structure of the molecule, both 
unliganded[140] and as complexes with substrate-derived inhibitors.[141] Additionally, 
backbone engineering and site specific labeling with NMR probe nuclei shed light on 
the  aspartyl protease catalytic mechanism.[142,143] 
Despite of its utility for studying small proteins (< 100 AA), stepwise SPPS has 
serious drawbacks: Poor solvation and formation of secondary structures of the 
growing, fully protected peptide chain may significantly reduce the efficiency at each 
synthetic step resulting in the accumulation of byproducts. In contrast to stepwise 
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SPPS, convergent synthesis uses the assembly of protected peptide fragments to 
prepare proteins. Although some larger proteins have been prepared using this 
strategy (GFP, 238 AA),[144] convergent synthesis suffers from poor solubility of 
protected peptides, low reaction rates and potential epimerization (racemization). 
Alternatively, chemoselective ligations have been developed, which allow linking of 
unprotected peptide fragments. 
 
1.2.1. Chemoselective ligation approaches 
 
Figure 1-5 presents some of the most popular and elegant reactions employed by 
synthetic organic chemistry known to date. With the exception of reaction A, they all 
rely on an initial capture step (either thioester- or imine-capture), which provides the 
entropic activation for the following intramolecular amine acylation step.[145,146] 
Chemoselective ligation was made more attractive by native chemical ligation (NCL) 
and, more recently, by a variation of the Staudinger reaction, both generating a 
native peptide bond at around neutral pH (Figure 1-5D,E).  
 
 
Figure 1-5: Selection of chemoselective coupling reactions for coupling of unprotected polypeptides in 
aqueous solution. A) Thioester forming ligation.[142] B) Imine-capture followed by tautomerization and 
pseudoproline formation.[147] C) Cystein ligation via thioalkylation capture of bromoalanine.[148] D) 
Cystein ligation through thioester capture by thiol-thioester exchange (native chemical ligation).[149] 
E) Staudinger ligation.[150,151] 
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The initial thiol-thioester exchange step in NCL is fully reversible, whereas the 
second acylation step is irreversible under the conditions used. Therefore, only the 
desired amide is formed, even in the presence of unprotected internal cysteine 
residues. In contrast, reactions A to C require acidic conditions or protection of 
internal cysteine residues (lysine in the case of B) to minimize side reactions. First 
described by Wieland,[152] NCL is restricted to peptide ligation sites at an Xaa-Cys 
bond, formed by reacting peptide fragments carrying either a C-terminal (Xaa-) 
α-thioester or an N-terminal cysteine residue (Figure 1-5D).  
Due to the naturally low abundance and often irregular distribution of cysteine 
residues in proteins, numerous approaches were tried to overcome this limitation. For 
example, the development of N-linked thiol auxiliary groups, which can be removed 
after peptide ligation, in principle† extended the applicability of NCL to any Xaa-Yaa 
peptide bond.[155,156]  
NCL has been widely used in the total synthesis of small proteins and protein 
domains (reviewed by [157]), but its utility was significantly broadened by the 
demonstration that both essential components (C-terminal α-thioester and N-terminal 
cysteine residue containing fragments) can be produced recombinantly. Whereas 
cysteine belongs to the 20 genetically encoded amino acids, activated thioesters are 
naturally rare, but have recently been shown to be key intermediates in the intein 
mediated splicing reaction of proteins. 
 
1.3. Inteins 
 
Inteins were first identified by two groups in 1990 as protein insertion sequences that 
are flanked by host protein sequences (N- and C-exteins) and must be removed by a 
posttranslational process termed protein-splicing.[158,159] In analogy to RNA splicing, 
the intervening intein sequence is precisely excised, and the flanking N- and 
C-exteins are joined by a normal peptide bond. So far more than 130 inteins were 
identified in eubacteria, archaea and lower eukaryotes including fungi and algae 
(InBase,[160] http://www.neb.com/neb/inteins.html). According to Evans and Xu[161] 
inteins can be divided into four basic classes: 
                                                 
† For unknown reasons, Cα-sterically hindered amino acids gave very poor ligation yields with any of 
the reported auxiliaries linked to the amino group. Therefore this approach, so far, is restricted to Xaa-
Gly/Ala ligation sites.[153,154] 
Introduction     15 
 
A. Maxi-inteins (or bifunctional inteins, Figure 1-6) have the typical N- and C-terminal 
splicing domains interrupted by a homing endonuclease, which permits intein spread 
to inteinless genes via a homing mechanism.[162] 
B. Mini-inteins were first generated by removing the endonuclease domain at the 
gene level, demonstrating that protein splicing domains alone were sufficient for 
protein splicing. A naturally occurring mini-intein was discovered later in the 
Mycobacterium xenopi gyrA gene.[163] 
C. Split-inteins (or trans-splicing inteins) lack a covalent linkage between their N- and 
C-terminal splicing domains. The two intein sequences reconstitute a functional intein 
which can undergo protein trans-splicing in vitro[164-166] and in vivo.[167] 
D. Alanine-inteins possess an alanine residue instead of the catalytic important 
cysteine/serine residue at the N-terminal splice junction and bypass the first step in 
the protein splicing mechanism.[168]  
Although the biological role of inteins and protein splicing remains unclear, the 
mechanism underlying this process has been studied and exploited extensively. 
 
 
 
 
 
 
Figure 1-6: Schematic illustration of the intein structure: Amino acid numbering system, primary 
sequence motifs, conserved residues and domain organization are indicated. An X stands for a 
nonconserved residue. 
 
 
 
Introduction     16 
 
1.3.1. Protein splicing mechanism 
 
With the exception of the alanine-inteins,[168] protein splicing consists of four 
concerted reactions of which the first three are selfcatalyzed‡ by the intein 
(Figure 1-7).  
The first step is activation of the N-terminal splice junction. An NÆS (O) acyl 
rearrangement at cysteine 1 (serine 1) moves the N-extein to the side-chain forming 
a linear (thio-)ester intermediate (for amino acid numbering see Figure 1-6).[170]  
 
 
 
Figure 1-7: Protein splicing mechanism for the Synechocystis sp. DnaB intein. Blue and red represent 
extein and intein residues respectively. Active site residues are colored black. Highly conserved 
residues are Thr70, His73, His153 and Asn154. See text for description. Modified from Ding et al.[175] 
 
                                                 
‡ The term self-catalyzed might be contradictory since the catalyst (the intein) is not regenerated in a 
form capable of performing additional reaction cycles. However, inteins display several features 
(e.g. substrate specificity, stabilization of reactive intermediates) characteristic of classical enzymes 
and may be viewed as primitive enzymes.[169]  
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Next, trans(thio-)esterification occurs when the activated thioester is attacked by the 
sulfhydryl (hydroxyl) group of cysteine+1 (serine+1) resulting in cleavage at the 
N-terminal splice junction and formation of a branched intermediate.[171] The branch 
is resolved by cyclization of the conserved intein C-terminal asparagine forming a 
succinimide.[172,173] The release of the intein leaves the N-extein attached to the side 
chain of cysteine+1 (serine+1) via a thioester (ester) bond, which is resolved by a 
spontaneous S (O)ÆN acyl transfer linking the N- and C-exteins via a native peptide 
bond.[174] The outlined mechanism is supported by extensive mutagenesis and 
structural studies, which enabled the precise manipulation of certain reaction steps 
and demonstrated that these can occur independently of each other.[176,177] Although 
protein splicing mediated by inteins inserted between foreign exteins is generally less 
efficient than splicing in the native context,[171] splicing has no strict sequence 
requirements in either of the exteins, except for the extein residues directly adjacent 
to the cleavage sites (Xaa-1/+1). This promoted the application of inteins as protein 
engineering tools, including the use of split inteins for protein head-to-tail 
cyclization,[178,179] segmental isotopic labeling to extend NMR analysis to larger 
proteins,[180,181] protein in-vivo labeling[182] and for detecting protein-protein 
interactions.[183,184] One of the earliest application of modified inteins, however, was 
based on their ability to generate thioester-tagged proteins for NCL. 
 
1.4. Expressed protein ligation and protein semi-synthesis 
 
Expressed protein ligation (EPL) is a variation of NCL in which one or more of the 
peptide segments used to assemble a protein is produced recombinantly, permitting 
synthetic peptides to be chemo- and regioselectively coupled to recombinant 
proteins.[185-187] EPL combines the structural flexibility of chemical (peptide) synthesis 
with the ability of recombinant DNA methodologies to generate large polypeptides 
(proteins), thereby enabling the semi-synthesis of much larger proteins. 
As shown in Figure 1-8, α-thioester derivatives of recombinant proteins can be 
prepared by thiolysis of mutated intein fusions. In this case the target protein is fused 
to the N-terminus of a modified intein, which cannot undergo C-terminal cleavage.[172] 
The intein catalyzes an NÆS acyl shift leading to a linear thioester linked 
intermediate, which can be cleaved by transthioesterification with thiol containing 
compounds, liberating the α-thioester tagged protein. Commercially available 
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systems additionally use affinity tags (mainly chitin-binding domain (CBD)), which 
allow facile affinity purification and inducible self-cleavage of expressed proteins.[188]  
If the α-thioester fragment is accessible by total synthetic means (< 50 AA), several 
protocols employing Boc- or Fmoc-based SPPS are now established and were 
recently discussed in detail by Hofmann and Muir.[189] 
In contrast, preparation of recombinant proteins bearing an N-terminal cysteine is 
often more complicated and always involves specific removal of an N-terminal leader 
sequence from a precursor protein. Proteolytic cleavage of an expressed protein 
precursor with the cysteine residue adjacent to a protease cleavage site was 
demonstrated by in vitro processing with tobacco etch virus (TEV) protease[190] and 
Factor Xa protease,[191,192] as well as in vivo, utilizing endogenous 
methionylaminopeptidase (MetAp).[193] Unfortunately, unspecific and often inefficient 
proteolysis and the requirement for a further purification step restrict the general 
applicability of these methods.  
 
 
Figure 1-8: Basic concept of EPL. Recombinantly expressed proteins bearing a C-terminal thioester or 
an N-terminal cysteine can be prepared by fusion to and subsequent cleavage of engineered inteins. 
The isolated fragments are ligated in a manner similar to NCL. 
Introduction     19 
 
As an alternative, C-terminal cleavage of Cys1Ala mutant inteins (which cannot 
undergo N-terminal cleavage) can be induced by a change in pH or temperature (see 
Figure 1-8.).[194] The target protein starting with a cysteine residue is fused to the 
C-terminus of a CBD-intein construct. Upon affinity purification and induction of 
splicing, the target protein carrying the N-terminal cysteine is released from the chitin 
column. Although no exogenous protease is required, spontaneous (even in vivo) 
cleavage may result in premature loss of the intein and the associated affinity tag. In 
summary, protein splicing and its modulation provide the means for site-specific and 
genetically codeable labeling of recombinant proteins, which can be further exploited 
by EPL or other techniques. 
Since its introduction, EPL has been applied to many different proteins (reviewed 
by [195]). In many cases, site-specific introduction of probes such as fluorophores, 
isotopes, affinity tags, posttranslational modifications or unnatural amino acids 
permitted the exploration of important functional questions. Most applications aim at 
modifications located within ~ 50 residues of the N- or C-terminus, which allows 
target molecule assembly from two fragments, one synthetic and one recombinant. 
Furthermore, sequential EPL strategies (i.e. the ligation of three or more fragments) 
offer the possibility to modify any residue within the entire primary protein 
sequence.[196,197]  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Aims of the project 
 
 
 
 
 
“Nature is wont to hide herself.” 
 
Heraclitus 
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2. Aims of the project 
 
The recent advances in the field of intein chemistry paved the way for the application 
of methods of synthetic organic chemistry to the modification of large proteins. Such 
a symbiosis of chemistry and biology can be considered to be extremely useful, for 
the generation of proteins, difficult or impossible to obtain by purely recombinant 
methods. For several reasons, prenylated Rab proteins represent ideal targets for a 
semi-synthetic strategy, as for example depicted in Figure 2-1. Such an approach, 
based on expressed protein ligation (EPL), would allow the production of 
geranylgeranylated proteins from two polypeptide fragments: a large, C-terminally 
truncated and unprenylated precursor fragment generated by recombinant 
techniques, and a short prenylated peptide derived from total synthesis, which 
completes the Rab C-terminus upon ligation.  
 
Figure 2-1: Expressed protein ligation (EPL) for the production of prenylated Rab GTPases. The 
approach permits the coupling of recombinantly derived thioester-tagged proteins to synthetic 
peptides. The lower part of the figure shows some applications of such proteins, which were explored 
in this study.  
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If applicable on a routine basis, the approach would circumvent many problems 
inherent to conventional expression and purification systems (see Chapter 1.1.3.). 
Furthermore, the power of organic chemistry to incorporate virtually any structure into 
the synthetic peptide component could permit the generation of a broad array of 
functionalized Rab proteins of defined structure. These functionalities, such as 
spectroscopic probes, affinity-tags or crosslinkers, are expected to drive the 
development of new experimental designs to further explore Rab protein function. 
Prenylated Rabs modified in this way cannot easily be obtained by traditional 
methods of protein chemistry. 
In the context of Rab proteins, the mechanism of geranylgeranylation catalyzed by 
GGTase-II/REP has been a subject of intensive research (see below). Although the 
molecular details leading to the formation of the catalytically competent enzyme-
substrate complex (the quaternary Rab:REP:GGTase-II:GGPP complex) are now 
credibly clarified, the steps following its assembly remain controversial. At least 
partially this is due to the poorly characterized single prenylated reaction intermediate 
complex, which transiently accumulates during the prenylation reaction, as well as 
due to a lack of time resolved methods to monitor the enzymatic conversion. In fact, 
chemically defined and homogenously single prenylated Rab proteins capable of 
accepting the second prenyl group cannot be generated by any established method. 
However, the semi-synthetic approach appears to be suitable to enable access to 
these proteins. 
Another field of active research is the structure elucidation of proteins involved in 
vesicular transport. In particular, general regulators that act on all Rab proteins, such 
as REP, GGTase-II or RabGDI, have received considerable attention. Structural 
studies typically require large amounts (i.e. several milligramms) of purified and 
prenylated Rab proteins, which are not easily obtainable. On condition that the 
prenylated peptide and the truncated Rab-thioester are readily accessible, the EPL 
reaction can also be expected to furnish prenylated Rabs in preparative amounts.      
This study aimed at the development of protocols permitting the semi-synthesis of 
prenylated Rab proteins by means of EPL. Ideally, such an approach is expected to 
be generally applicable to different Rabs and different peptides and capable of 
producing large amounts of pure and homogenous protein material in a short period 
of time. In order to demonstrate the usefulness of the approach as well as to gain 
further insights into the prenylation reaction, Rab proteins carrying a single prenyl 
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group attached to either biologically relevant cysteine residue as well as the doubly 
modified form were envisaged. These structures can be expected to shed new light 
on the interaction of GGTase-II with its single prenylated reaction intermediate(s) and 
double prenylated product.  
A further aim of this work was to provide sufficient amounts of prenylated Rab 
proteins complexed to various interacting proteins for further crystallographic studies.  
The work was carried out in close collaboration with members of Prof. Dr. 
Waldmann´s lab at the MPI-Dortmund. The prenylated peptides used throughout this 
study (unless otherwise indicated) were synthesized and provided by Dr. Ines 
Heinemann, Dr. Lucas Brunsveld and Anja Watzke. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results and Discussion 
 
 
 
 
 
“The most exciting phrase to hear in science, 
 the one that heralds the most discoveries, 
 is not ´Eureka!´, but ´That's funny´.” 
 
Isaac Asimov 
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3. Results and Discussion 
3.1. Development of a semi-synthetic strategy facilitating access to 
prenylated Rab/Ypt proteins 
 
Key to the outlined objectives was the elaboration of detailed and generally 
applicable protocols, which should enable production of semi-synthetic Rab/Ypt 
proteins by means of EPL. EPL was extensively applied to a variety of different 
proteins and peptides.[195,198] In the context of small GTPases, EPL was recently used 
to generate fluorescently labeled unprenylated Rab7 protein,[199] which has proven to 
be a valuable tool for spectroscopic interaction studies.[106,116,118] Moreover, a 
different semi-synthetic strategy based on maleimidocaproyl (MIC) coupling to a 
single surface exposed cysteine residue was exploited to produce farnesylated 
(C15 isoprenoid) and otherwise modified Ras proteins.[200] One could conjecture that 
these developed procedures could also be directly applied to the EPL mediated 
semi-synthesis of geranylgeranylated Rab proteins. However, for reasons discussed 
below, this turned not out to be the case.  
The first part of this chapter (3.1.) will demonstrate and discuss the development of a 
suitable strategy for EPL semi-synthesis of prenylated Rab proteins, whereas the 
following chapters (3.2.-3.5.) will deal with potential applications of proteins 
generated in such a manner. 
3.1.1. General considerations – Case studies  
 
The utility of EPL stems from its undemanding structural requirements, i.e. any 
α-thioester can theoretically be coupled to any N-terminal cysteine containing peptide 
in the presence of fully unprotected functional groups usually found in proteins. 
However, depending on the application of the resulting semi-synthetic proteins, 
certain criteria regarding the design of the peptide fragment should be considered in 
order to meet different experimental needs: 
1. The synthetic peptide fragment should be small (2-10 AA) in order to minimize the 
synthetic effort and should resemble (or ideally match) the wild type sequence as 
close as possible. The significance of this prerequisite is underlined by the 
importance of the C-terminal region for Rab membrane targeting and anchorage. 
Figure 3-1 reveals that in some cases certain deviations from the wild type structure 
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are inevitable due to the planned experimental intentions and synthetic requirements. 
For example, semi-synthetic Rab7 proteins with a different geranylgeranyl pattern 
were designed for studying their interactions with GGTase-II by means of 
fluorescence spectroscopy (see Chapter 3.2.). The synthetic peptide fragment was 
thought to contain both prenylateable cysteine residues and an additional N-terminal 
cysteine for coupling to truncated Rab7 proteins (synthetic necessity). However, the 
next possible native cysteine upstream of the prenylation cysteines is Cys143, which is 
buried in the GTPase domain. Such a large truncation (Rab7∆64) is likely to affect 
the GTPase fold and accessibility of the Rab-thioester group, besides requiring a 
huge synthetic effort for obtaining the complementing prenylated 64-mer peptides. 
Thus, as a compromise the ligation site was placed between Ser201 and Ala202, which 
formally resulted in a Ala202Cys mutation, an exchange that can be expected to be 
neglectable (Figure 3-1).[199] 
 
 
 
Figure 3-1: Development of a semi-synthesis strategy for Rab7. The ligation site was placed between 
Ser201 and Ala202. Three types of peptides (series A-C) with different fluorophore attachment sites were 
considered (FL = fluorescence label, GG = geranylgeranyl, OMe = methylesterification of the Rab 
C-terminus). 
 
In the context of choosing the site of ligation,[201] it is also important to consider the 
identity of the C-terminal amino acid residue in the thioester-containing peptide 
segment. Although all 20 naturally occurring amino acids are suitable for NCL when 
placed at the C-terminus of an α-thioester model peptide, some of them are 
associated with extremely slow reaction rates (e.g. Ile, Val and Pro).[202] Moreover, 
when the thioester-containing peptide segment is intended to be produced by 
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bacterial expression systems, the nature of this amino acid also appears to influence 
the cleavage of the intein-fusion protein (see chapter 3.1.2.).[203]  
In the case of the above mentioned Rab7 project, an additional modification was 
necessary in order to incorporate a sensitive fluorescent probe, which in principle 
could be attached to various sites of the peptide. 
 
2. The positioning of a non-native reporter group is often a compromise between 
seeking a site that gives highly sensitive and specific signals and, on the other hand, 
reducing the potential adverse influence of the introduced modification on the effect 
under study to a minimum. At the beginning of this study no structural data 
concerning the interaction of Rab/Ypt proteins with REP-1 and GGTase-II or RabGDI 
were available, hindering an optimal structure-based positioning of the fluorophore. 
Figure 3-1 demonstrates three positions, to which a fluorophore or any other 
modification can be introduced into the peptide. First, the fluorophore could be 
attached to the side chain of amino acids flanking the prenylateable cysteines. In this 
study Glu203 directly adjacent to the ligation cysteine was replaced by lysine, which 
allows the ε-amino group to be further functionalized by alkylation or acylation. 
Introduction of the small dansyl fluorophore via a sulphonamide linkage at this site 
was shown to have no impact on the interaction of Rab7 with REP-1 and GGTase-II 
and not to affect prenylation or the rate of Rab GTP hydrolysis.[199] Still, bulkier 
fluorophores appear to interfere with the prenylation reaction (Dr. Alexandrov, MPI-
Dortmund, unpublished observations) suggesting the exploration of alternative sites.  
Secondly, fluorophores could be incorporated into the isoprenoid group(s). These 
functionalized prenyl analogs (Figure 3-2), which resemble the native geranylgeranyl 
lipids in length, have been used in many cases for studying certain aspects of protein 
isoprenylation[204-206] and isoprenoid-protein interaction.[207,208] Two types of analogs 
are frequently employed: photoactivatable derivatives,[208] which enable photoaffinity 
labeling (PAL) to interaction partners upon photoirradiation, and fluorescent analogs. 
In some of the reported cases the biological in vivo activity of such engineered 
proteins is retained despite the modification.[209,210] However, depending on the 
hydrophobicity and bulkiness of the analogs used, this outcome cannot always be 
expected.  
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Figure 3-2: Isoprenoid modifications. Geranylgeranyl (1) and fluorescent and photoactivatable 
analogs. Didehydrogeranylgeranyl (∆∆GG, 2),[207] mant (3) or dansyl (4) labeled geranyl (n = 1) or 
farnesyl (n = 2) derivatives as examples for fluorescent analogs.[204,206] Benzophenone (5) and 
2-diazo-3,3,3-trifluoropropionyloxy (DATFP, 6) derivatives  as photoactivatable analogs.[208-212]  
 
Thirdly, fluorophores could be attached to the C-terminal α-carboxyl group. In the 
case of Rab7 this would lead to replacement of the methylester, which arises from a 
posttranslational modification affecting all Rabs terminating in CXC.[103] The precise 
molecular role of this methylesterification is not understood and therefore the 
consequences of its modification cannot easily be predicted. Although apparently not 
required by the majority of Rab proteins and despite its small size, 
methylesterification was found to contribute significantly to the hydrophobicity[213] and 
membrane binding potential[214-216] of prenylated model peptides. Furthermore, 
carboxymethylation seems to be required for efficient in vitro membrane binding of 
prenylated Ypt5 protein,[217] and controlled methylation/demethylation was also 
postulated to developmentally regulate the function of Rab3D.[218] In this study 
substitution of the Rab7 methylester with a dansyl derivative was employed for 
studying its consequences on the ability of Rab7 to interact with REP-1 and RabGDI 
(Figure 3-1). 
In conclusion, the lack of information concerning the precise molecular role of a) the 
C-terminal peptide tail, b) the geranylgeranyl isoprenoids, and c) the carboxy-
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methylation largely precluded a rational positioning of a reporter group. Thus different 
sites had to be tested, in order to assess the consequences of the fluorophore 
incorporation at each position. On the other hand, many other potential applications 
of prenylated Rab proteins do not strictly require additional reporter groups (e.g. 
crystallographic analysis). Especially in cases where the Rab protein contains a CC 
prenylation motif, the synthetic effort could be reduced to Cys-Cys(GG) dipeptides or 
Cys-Cys(GG)-Cys(GG) tripeptides, depending on whether single or doubly 
prenylated proteins are desired (Figure 3-3).  
 
 
 
Figure 3-3: Development of a semi-synthesis strategy for Rab5 and Ypt1.  
 
3. From the perspective of chemical synthesis, geranylgeranylated peptides can be 
prepared employing solid- or solution phase methods (see [219-222]). Although not 
subject of this study, for the semi-synthetic strategy it is important to note the 
pronounced acid-lability of isoprenoids, giving rise to addition and rearrangement 
reactions.[223] Together with the well known base-lability of thioesters, this largely 
restricts the EPL reaction conditions to neutral pH.  
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3.1.2.  Expression and purification of Rab/Ypt C-terminal 
α-thioesters 
 
The bacterial expression strategy for generation of truncated Rab protein α-thioesters 
is shown in Figure 1-8. This requires the truncated target Rab gene to be inserted 
upstream of an intein-chitin-binding-domain (CBD) construct. Following expression 
and affinity purification of the three-part fusion protein, the Rab protein of interest is 
precisely cleaved from the intein-CBD as a C-terminal α-thioester. Several E. coli 
expression vectors are now commercially available that allow the target DNA to be 
easily subcloned in frame of various engineered inteins (for review of commercially 
available intein vectors see [203,224]). All vectors utilize the T7/lac promoter to provide 
stringent control of fusion protein expression[225] and a chitin-binding domain (5 kDa) 
from Bacillus circulans.[226] Two vectors that were frequently used in this study are 
depicted in Figure 3-4.  
 
 
 
Figure 3-4: Commercially available intein vectors A) The pTWIN1 vector utilizes two mini-inteins. 
Depending on the cloning strategy, target proteins can be fused C- and/or N-terminally to the inteins. 
B) The pTYB1 vector employs the Saccharomyces cerevisiae vacuolar membrane ATPase (Sce VMA) 
maxi-intein as a C-terminal fusion. MCS = multiple cloning site, CBD = chitin-binding domain. 
 
Although in practical terms it is difficult to know which intein expression system will 
work best for a given target protein, it is advisable to consider the following points for 
choosing a suitable intein vector. First, intein cleavage is mainly affected by the 
nature of the extein amino acid adjacent to the scissile peptide bond.[203,224] Certain 
amino acids are associated with intein inactivity, premature in vivo cleavage and low 
reaction rates, when used in combination with particular inteins. Because inteins 
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have different amino acid preferences for this position, the choice of the split site 
(often identical with the later ligation site) and of the intein should be considered 
together. Secondly, the size of the intein used might affect the soluble expression 
levels of the corresponding fusion protein.[201,227] For example, the S. cerevisiae 
vacuolar membrane ATPase intein (Sce VMA1, 455 AA, present in pTYB type 
vectors) is significantly larger than the Mycobacterium xenopi DNA gyrase A intein 
(Mxe GyrA, 198 AA, available in pTXB type and pTWIN1 vectors), due to the 
presence of an additional endonuclease domain. As a result, the small size of the 
Mxe GyrA intein permitted in many cases the fusion protein to be in vitro refolded 
from inclusion bodies,[228,229] whereas the Sce VMA1 intein was shown to refold less 
efficiently.[230,231] This property might become handy in the case of cytotoxic proteins, 
which can often only be expressed under conditions that favor inclusion body 
formation (and hence inactivation of the protein) and have to be refolded during 
purification.[228] 
All truncated Rab/Ypt protein thioesters were expressed as C-terminal intein fusions§ 
using pTYB1 or pTWIN1 expression vectors (see Figure 3-4). Vectors were prepared 
using standard PCR subcloning procedures employing in most cases ligation sites 
recommended by New England Biolabs.[224] The various expression vectors were 
then transformed into BL21(DE3) cells and a series of preliminary studies undertaken 
to identify optimal expression conditions (IPTG concentration, induction time and 
temperature were varied). For soluble Rab/Ypt fusion protein expression the 
induction temperature had to be lowered to 18-22° C in all cases examined so far.[232] 
At more elevated temperatures, inclusion body formation was observed for the 
Mxe GyrA as well as for the Sce VMA1 intein fusion proteins.  
Purification of the Rab/Ypt fusion proteins from crude cell extracts employing chitin 
agarose beads was straightforward. The tight binding of the CBD to the chitin matrix 
permits non-specifically bound material to be removed utilizing stringent wash 
conditions (e.g. high salt concentration or use of non-ionic detergents). However, 
prolonged storage (> 1 d) of the immobilized fusion protein under such conditions led 
to a significant reduction of the intein´s cleavage efficiency and an increased 
premature release of the target protein. In practical terms, it is advisable to work as 
fast as possible at a constant temperature of 4° C. Starting with crude cell lysate the 
whole procedure should reach the thiol induced cleavage stage within 4-6 hours. 
                                                 
§ i.e. the Rab C-terminus is fused to the N-terminus of the intein-CBD construct. 
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In principle thiol-induced cleavage and ligation to a N-terminal cysteine containing 
peptide fragment could be carried out simultaneously in a one-pot reaction by simply 
adding peptide and thiol additive to the immobilized intein fusion protein.[185,186,197,230] 
However, this approach restricts the application of additives that can be present in 
the reaction mixture, since the intein must remain folded and active during the ligation 
reaction. Taking into account the observed instability of the immoblized fusion protein 
(see above), it appeared more advantageous to isolate and characterize the 
recombinant protein α-thioesters first. 
Cleavage was in all cases performed in the presence of 
500 mM 2-mercaptoethanesulfonic acid (MESNA) at room temperature for 12-16 h. 
Beside MESNA,[187] a variety of compounds were tested for the induction of thiolysis 
of the intein fusion proteins including 3-mercaptopropanesulfonic acid (MPSNA),[230] 
DTT,[188] β-mercaptoethanol (β-ME),[188] ethanethiol[181] and thiophenol.[230] In contrast 
to MESNA, these compounds partially have the disadvantage of low solubility in 
aqueous buffers at around neutral pH (e.g. thiophenol), a high tendency for 
spontaneous oxidation forming insoluble symmetrical disulfides (thiophenol), a high 
hydrolysis rate of the respective α-thioesters (MPSNA, thiophenol),[230] an unpleasant 
odor (thiophenol, β-ME, ethanethiol) and a low reactivity in subsequent EPL (NCL) 
reactions (ethanethiol, DTT, β-ME). In practical terms the last point is usually of less 
significance, since the reactivity can be reestablished by in situ trans-thioesterification 
during the ligation reaction with more potent thiol compounds (e.g. thiophenol, 
see 3.1.3.).[233,234]  
Incubation of the Rab/Ypt-intein fusion protein with such high concentrations of 
MESNA (0.5 M) resulted in almost quantitative cleavage (see Figure 3-5). It was also 
observed that these conditions led to denaturation of a minor fraction (< 5 %) of CBD 
containing polypeptides, which were released from the chitin column along with the 
desired Rab/Ypt α-thioesters. These minor impurities were considered acceptable, 
since additional purification steps following EPL were performed in any case.     
Using a single affinity chromatographic step, 20-40 mg of Rab/Ypt thioester protein 
(corresponding to 40-120 mg of fusion protein) were typically obtained per liter of 
bacterial culture in excellent purity (> 90 %). Expression levels, cleavage efficiency 
and final yields were in general slightly higher for the Mxe GyrA intein fusion proteins 
(pTWIN1 vector) as compared to the Sce VMA1 intein fusion proteins (pTYB1 
vector).  
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Figure 3-5: Expression and purification of Rab7∆6-MESNA thioester. A) SDS PAGE of crude cell 
extract from BL21(DE3) E. coli cells before induction with IPTG (lane 1), after induction and 
expression at 20° C for 10 h (lane 2) and after incubation with chitin-binding beads (lane 3). Chitin-
binding beads after washing (lane 4) and after MESNA induced cleavage (lane 5), resulting in elution 
of the Rab7∆6-MESNA thioester (lane 6). Arrows indicate the position of Rab7∆6-Sce VMA1 intein-
CBD (a), Sce VMA1 intein-CBD (b) and Rab7∆6-MESNA thioester (c). M = protein standards B) 
LC-MS spectrum of the purified protein. The inset shows the original data before deconvolution. The 
theoretical molecular mass of 2-201Rab7∆6-MESNA is 22932.1 Da. 
 
The identities of the produced proteins were confirmed by MALDI-MS, LC-ESI-MS 
and SDS-PAGE (Figure 3-5). The expressed Rab-fusion proteins were in many 
cases fully processed in vivo by the endogenous methionylaminopeptidase (MetAp) 
resulting in the cleavage of the starting methionine residue. The processing was 
dependent on the nature of the following (second) amino acid residue and was found 
to be in agreement with previous observations.[235] Moreover, using LC-ESI-MS 
analysis the presence of the reactive thioester could be inferred from its susceptibility 
to hydrolysis under slightly basic conditions (pH 9-10, see Figure 3-6). Under neutral 
conditions the MESNA α-thioesters could be stored at -20 or -80° C for several 
months, generally without any detectable decomposition or loss of ligation efficiency.  
3.1.3.  An unexpected behaviour of Rab5 thioesters terminating in 
glutamine or asparagine 
 
The described procedure allows generation of various thioester tagged proteins of 
defined molecular structure on a routine basis. In all cases mass spectroscopic 
analysis gave unambiguous results concerning the identities of the expected 
proteins, which was later confirmed in biochemical studies. Unexpectedly, Rab5∆5 
and Rab5∆4 MESNA thioester proteins were found to exhibit molecular masses of 
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about 130 Da less than expected, which could be explained by thioester hydrolysis or 
exo-proteolytic cleavage of a single amino acid residue.  
 
 
Figure 3-6: Susceptibility of protein α-thioesters towards mild alkaline hydrolysis and possible 
succinimide and glutarimide formation in the case of terminal asparagine and glutamine α-thioester 
residues. Rab7∆6 (A, B), Rab5∆5 (C, D) and Rab5∆4 (E, F) were incubated at 37° C for 30 min at a 
pH of 9-10. Samples before (A, C, E) and after (B, D, F) hydrolysis were analyzed by LC-ESI-MS. 
Proposed structural modifications of the C-terminal amino acid residue together with the 
corresponding calculated mass (blue) are shown for all proteins (Ser201 for Rab7∆6, Asn210 for Rab5∆5 
and Gln211 for Rab5∆4). Alkaline treatment may additionally result in deamidation at Gln and Asn 
residues giving rise to an additional mass shift of +1 Da. Such a small shift cannot be confidently 
detected, since the accuracy of the method is in the same range (± 1 Da).  
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Initially, the latter interpretation was favored since the ligation efficiency of both 
proteins toward the peptide H-Cys(StBu)-Lys(Dans)-Cys(GG)-OMe was essentially 
indistinguishable when compared to Rab7∆6-MESNA thioester (Figure 3-7C). 
However, when subjected to mild alkaline conditions, both proteins exhibited a mass 
shift of ca. +18 Da, which is in contradiction to a mass shift of -124 Da observed upon 
alkaline hydrolysis of the Rab7∆6-MESNA thioester (Figure 3-6). Sequence analysis 
of the Rab5a∆4 and ∆5 mutants revealed the identities of the C-terminal amino acid 
residues as glutamine and asparagine, respectively (Figure 3-3). These observations 
could be interpreted with the formation of a five-membered succinimide ring in the 
case of C-terminal asparagine, and of a six-membered glutarimide ring in the case of 
C-terminal glutamine (Figure 3-6 and 3-7A).         
 
 
 
Figure 3-7: A) Proposed mechanism for spontaneous succinimide formation and possible side-
reactions during EPL or NCL giving rise to isomerization of the terminal asparagine residue. An 
analogous pathway could be considered for terminal glutamine residues. B) Expression and 
purification of Rab5∆5-MESNA thioester analyzed by SDS-PAGE. Crude cell lysate from uninduced 
(lane 1) and induced (lane 2) cells. Lysate after depletion of the CBD-fusion protein with chitin beads 
(lane 3). Chitin beads before (lane 4) and after (lane 6) MESNA induced cleavage. The supernatant 
after thiol-induced cleavage is shown in lane 5. Note that the fusion protein exhibits only a minor 
tendency for spontaneous (uninduced) cleavage. Arrows indicate the position of Rab5∆5-Mxe GyrA 
intein-CBD (a), Mxe GyrA intein-CBD (b) and Rab5∆5 (c). C) Ligation of Rab7∆6 (lane 1), Rab5∆5 
(lane 2) and Rab5∆4 thioesters/imides to the peptide H-Cys(StBu)-Lys(Dans)-Cys(GG)-OMe in the 
presence of 150 mM MESNA and 50 mM CTAB. The reactions were analyzed by SDS-PAGE. Product 
formation could be inferred from the appearance of a fluorescent band in the 20-30 kDa molecular 
weight range.     
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In such a scenario, the nitrogen of the β- or γ-carboxamide group attacks the 
thioester-activated carbonyl carbon of the asparaginyl/glutaminyl residue, leading to 
intramolecular cyclization and displacement of the thiol leaving group. The proposed 
structures of  the occuring thioester/imide species are in excellent agreement with the 
mass spectroscopic observations (Figure 3-6).  
Interestingly, the formed imides were capable of reacting with the peptide 
H-Cys(StBu)-Lys(Dans)-Cys(GG)-OMe yielding a covalently linked (fluorescent) 
product (Figure 3-7C). Therefore, under the employed EPL reaction conditions** 
imides seem to represent reactive compounds. Indeed, (N-alkylated) succinimides 
originating from asparaginyl and aspartyl cyclization have been observed in model 
peptides[236,237] and proteins[238,239] and typically give rise to deamidation, 
isomerization, racemization and polypeptide cleavage under physiological 
conditions.[240,241] Furthermore, studies of the alkylation reaction of thiol-containing 
compounds (e.g. cysteine residues in proteins) with maleimide derivatives could 
show that the formed succinimide thioether can undergo a number of chemical 
transformations at the imide functionality at around neutral pH and room 
temperature.[242-249] This typically involves ring opening by nucleophiles and results in 
the formation of succinamic acid derivatives. 
Taken together these data strenghten the assumption that the observed protein 
succinimide and glutarimide can possibly undergo various fates during an NCL/EPL 
reaction. Direct aminolysis of the Rab imides could be excluded, since the prepared 
proteins failed to react with H-Lys(Dans)-OH (not shown). It therefore appears 
plausible that under the employed conditions** ring opening by thiol nucleophiles, 
such as cysteine containing peptides or MESNA, could restore the thioester 
(see Figure 3-7A). In this case, the consequence would be the formation of the 
unnatural β (γ) peptide bond between Asn (Gln) and Cys as a EPL side product 
(isomerization), since both carbonyl groups are expected to have similar reactivities.  
The proposed mechanism offers a explanation for the above mentioned observations 
and resembles the mechanism of NCL side reactions with aspartic or glutamic acid 
as C-terminal α-thioester residues recently reported by Villain et al.[250] In these cases 
extensive hydrolysis and isomerization were observed, possibly due to an analogous 
anhydride forming cyclization of the activated dicarbonic acids. The problem can be 
                                                 
** i.e. at around neutral pH in aqueous solution and in the presence of MESNA and CTAB. See 
chapter 3.1.4. for a discussion of the effect of CTAB on the nucleophilicity of thiol containing 
compounds. 
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minimized by employing appropriate side-chain protecting groups for the C-terminal 
α-thioester residue, provided this fragment is accessible by total synthetic means.[250] 
In conclusion, despite the fact that all 20 naturally occurring amino acids were found 
to be compatible in a Xaa-Cys ligation,[202] one should try to avoid Asp, Asn, Glu or 
Gln residues, especially when side product separation and detection is critical, as is 
usually the case for most larger polypeptides (> 10 AA). 
3.1.4. Expressed protein ligation with prenylated peptides   
 
With the Rab α-thioester proteins available, we set out to undertake ligation reactions 
with short prenylated model peptides, which were synthesised by Dr. Ines 
Heinemann from the Department of Chemical Biology, MPI Dortmund. Typically, EPL 
is carried out in aqueous buffers (pH 7-8) at temperatures between 4 and 40° C. It is 
desirable to have both reactant polypeptides at high concentrations (> 1 mM) and the 
synthetic peptide in large molar excess (3-10 times) in the reaction mixture in order to 
improve the ligation yields. Additives such as chaotropes,[149] detergents or organic 
solvents might help to increase the solubility of the reactants and are fully compatible 
with EPL.[201] The rate and the yields of the ligation reaction can be further enhanced 
by adding catalytic thiol cofactors, such as thiophenol or MESNA,[233] which retain the 
cysteine side chains in the reduced state, reverse the formation of unproductive 
thioesters and activate less reactive thioesters by transthioesterification.  
Initial studies on the ligation of geranylgeranylated peptides with Rab-MESNA 
thioesters were carried out using the tripeptide H-Cys-Lys(Dans)-Cys(GG)-OMe 
(see Table 5-2) and Rab7∆6-MESNA thioester. This fluorescently labelled model 
peptide permits easy detection of Rab7 ligation products by means of SDS-PAGE 
when the unstained gel is exposed to UV light. In such a case, appearance of a 
fluorescent band in the 20-30 kDa molecular weight region indicates the formation of 
the ligation product. In contrast, the increase in apparent molecular weight cannot 
always be revealed by a significant change in the electrophoretic mobility of the Rab 
protein. 
Not surprisingly, geranylgeranylated peptides, as for example shown in Table 5-2, 
were found to be essentially insoluble in pure aqueous solutions. Given the 
hydrophilic nature of the thioester fragment, conditions had to be identified under 
which both molecules could be maintained in solution, thus allowing their efficient 
ligation. The solubility problem could be partially overcome by supplementing the 
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reaction mixture with polar organic solvents (up to 70 % (v/v) of DMSO, ACN, EtOH, 
MeOH), 6 M GdmHCl or detergents. Despite the apparent solubilizing effect of the 
additives used, initially only high concentrations of the detergent SDS resulted in 
detectable EPL product formation with Rab7∆6-MESNA thioester protein. Because 
SDS is well known for its tight binding to proteins leading to protein denaturation and 
is difficult to remove from protein containing solutions due to its low cmc value,[251] a 
usage of this detergent in further studies was not envisaged††. Nonetheless, these 
encouraging results prompted us to search for alternative detergents supporting 
solubilization of reactants and enabling EPL. To this end, more than 80 detergents 
were screened in the above mentioned ligation reaction assay (Figure 3-8).  
 
 
 
 
Figure 3-8: Identification of detergents that support in vitro ligation of prenylated peptides. A) Ligation 
of Rab7∆6-MESNA thioester to H-Cys-Lys(Dans)-Cys(GG)-OMe in the presence of detergents. SDS-
PAGE gels exposed to UV irradiation identified successful ligation reactions by the appearance of 
fluorescent protein bands in the molecular weight range of 20-30kDa. B) Structures of detergents that 
are able to support in vitro ligation of prenylated peptides. Cetyltrimethylammonium bromide (CTAB), 
N-dodecyl-N,N-(dimethylammonio)butyrate (DDMAB), sodium dodecyl sulfate (SDS), n-octyl-phospho-
choline (FOS-Choline-8), lauryldimethylamine-N-oxid (LDAO) and cyclohexyl-ethyl-β-D-maltoside 
(Cymal-2). 
 
                                                 
†† During the time this work was performed, a study employing SDS as a solubilizing additive for EPL 
was published. However the studied protein is exceptionally (!) stable towards SDS-denaturation.[228] 
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Surprisingly, only very few detergents capable of efficiently supporting the ligation 
reaction were eventually identified (Figure 3-8): cetyltrimethylammonium bromide 
(CTAB), N-dodecyl-N,N-(dimethylammonio)-butyrate (DDMAB), sodium dodecyl 
sulfate (SDS), n-octyl-phosphocholine (FOS-Choline-8), lauryldimethylamine-N-oxid 
(LDAO) and cyclohexyl-ethyl-β-D-maltoside (Cymal-2). This low number of EPL-
effective detergents (6 out of 80) was striking since most of the tested detergents 
were able to mediate solubilization of the lipidated peptide, suggesting that 
solubilization, albeit a prerequisite, is not sufficient for ligation. Moreover, ligation of 
the peptide H-Cys-Lys-Lys-Arg-Arg-Leu-Lys-Cys(GG)-NH-(CH2)2-NH-Dans‡‡, which 
is excellently soluble in detergent free aqueous solutions,  onto Rab7∆6-MESNA 
thioester can be significantly improved by addition of low concentrations of the 
detergent CTAB (Figure 3-9A). This compound exhibited the highest potential for 
EPL reactions of prenylated peptides when present at concentrations above its cmc 
(typically 30-50 mM) and was used in all further studies (Figure 3-8).  
Comparison of the effective detergents did not reveal a common structural or 
physico-chemical (e.g. cmc value) feature, which could explain their remarkable 
impact on the EPL reaction. However, with the exception of Cymal-2 all of the 
effective detergents represent alkyl ionic or zwitter-ionic detergents, whereas most of 
the ineffective detergents belong to the non-ionic detergents. In general the latter are 
known to be mild detergents, which preserve the native protein structure, while the 
former nearly always act as denaturants and potent protein solubilizers.[254,255] One 
could speculate that the combined incorporation of prenylated peptide and 
thioester-tagged protein into the micellar aggregate results in the concentration of 
both reactants into a small volume (the micellar phase). As a consequence the 
frequency of molecular collisions can be expected to increase due to the close 
association of the two reacting species. Such a proximity effect (also referred to as 
the pseudophase model of micellar catalysis) is often the main factor responsible for 
the observed rate enhancement of bimolecular reactions in micellar solutions.[256] 
Indeed surfactant micelles have been known for the last 50 years to affect the 
reaction rate, mechanism and regio- and stereoselectivity of all kinds of chemical 
reactions.[256-258] In mechanistic terms, beside concentrating reactants within their 
                                                 
‡‡ This peptide sequence was derived from the C-terminus of the Ral-A GTPase from Drosophila 
melanogaster and was synthesized by Daniel Gottlieb, Department of Chemical Biology, 
MPI-Dortmund. Ral GTPases constitute a family of proteins within the Ras branch of small 
GTPases.[252,253] 
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small volumes,[259-261] micelles have been proposed to stabilize substrates, 
intermediates or products, to orient substrates, and to change ionization potentials, 
dissociation constants and consequently reactivities. In the present case the 
contribution and significance of these effects on the EPL reaction is quite speculative. 
Nevertheless, specifically the cationic detergent CTAB has been reported to 
decrease the pKa value of protein sulfhydryl groups by one or two pH units probably 
by stabilizing the ionized S− form of the thiol.[262] Similar changes of the pKa value in 
the presence of cetyltrimethylammonium cations have been observed for 
benzimidazole and substituted phenols.[263] Thus at a given pH, addition of CTAB 
might increase the fraction of the thiolate form of the C-terminal peptide fragment 
and, since this species represents the actual nucleophile in a EPL/NCL reaction, 
might account for the observed enhancement in reactivity. In this context it is 
important to note, that the fraction of the thiolate ions in a NCL reaction cannot be 
increased by simply raising the pH due to the pronounced base-lability of the 
activated thioester. 
Micellar bound amphiphilic solutes, e.g. prenylated peptides, orient themselves so 
that the polar region (peptide backbone and the reactive groups) interacts with the 
surfactant head groups in the Stern-layer, while the hydrophobic end (geranylgeranyl 
moiety) contacts the hydrocarbon tails of the micelle interior (Figure 3-9B). The high 
charge density on the micelle surface could additionally contribute to the polarization 
of the carbonyl thioester, thereby enhancing its reactivity.  
  
 
Figure 3-9: A) Ligation of the water-soluble Ral-A peptide to Rab7∆6-MESNA thioester. Peptide 
equivalents used in the reaction mixture are indicated with respect to thioester-tagged protein. The 
reactions were analyzed by SDS-PAGE. Product formation was detected by exposing the unstained 
gel to UV light. B) Hypothetical model of the micelle catalysis effect of CTAB. Rab7 thioester is colored 
red and the geranylgeranylated peptide is shown in blue. 
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The hydrophobic character of the reactants is generally believed to mainly control 
their reactivities, i.e. increasing the hydrophobicity increases the influence of the 
micellar phase on the reaction (e.g. [261,264]). Therefore, one can expect a less 
significant role of the surfactant on NCL/EPL reactions with unprenylated peptides 
with higher hydrophilicity. On the other hand the remarkable properties of these 
detergents could prove especially useful for the EPL/NCL mediated (semi-) synthesis 
of integral membrane proteins. In such cases, the limited solubility of hydrophobic 
membrane polypeptides in aqueous solvents remains a substantial experimental 
challenge.[228,265-267] Interestingly, Hunter et al.[268] very recently described the utility of 
cubic lipidic phase (CLP) matrixes as NCL reaction media, which, due to their 
exceptional properties, seem to have certain advantages over classical micellar or 
liposomal systems.  
In order to prove the specificity of the reaction and the reliability of the SDS-PAGE 
assay as well as to confirm the identity of the desired product, control ligations were 
carried out with various peptides under different conditions (Figure 3-10). 
 
Figure 3-10: Control reactions. Ligation of Rab7∆6-MESNA thioester (lanes 2 to 9) or Rab7∆6-OH 
(lane 1) to different peptides in the presence or absence of MESNA and CTAB. The reactions were 
analyzed by SDS-PAGE. The gel was subsequently illuminated with UV-light indicating product 
formation by the appearance of a fluorescent band in the molecular weight region of 20-30 kDa.  
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Product formation required a C-terminal α-thioester on the N-terminal fragment and 
the presence of an unprotected α-amino and β-mercapto group on the C-terminal 
fragment. Reductively cleavable β-mercapto protecting groups (e.g. StBu) can be 
cleaved off in situ by addition of an excess of thiol agent (MESNA, DTE, β-ME), as 
was previously reported.[198] The minor product formation observed in the absence of 
MESNA (lane 3) could be attributed to a residual amount of MESNA in the Rab-
thioester preparation or to a spontaneous reduction of the peptide during peptide 
purification or ligation. As pointed out above, CTAB was essential for a efficient 
ligation. These results suggest specific labeling of the Rab protein exclusively at the 
C-terminus and are in full agreement with the proposed NCL/EPL reaction 
mechanism.[149]  
The extent of ligation after 8-12 h was found to be essentially independent of the 
reaction temperature in the range of 25-40° C. On account of the relatively high 
Krafft point§§ of CTAB of ca. 22° C, reactions were typically not performed at 
temperatures lower than 30° C. 
So far, the devised reaction conditions permitted any Rab α-thioester to be ligated to 
any prenylated peptide bearing an N-terminal cysteine with excellent yields 
(50-90 %). The peptide was usually present in large molar excess (10 equivalents 
with respect to thioester-tagged protein). Hence, upon completion of the ligation 
reaction, ligated protein must be purified from contaminating peptide, unligated 
protein and potentially harmful detergent or additive (MESNA), which unexpectedly 
turned out to be highly problematic.   
3.1.5. Development of a purification strategy. 
 
Conjugation of Rabs with geranylgeranyl isoprenoids renders these proteins 
insoluble in aqueous solutions in the absence of membranes, suitable detergents or 
their natural chaperones REP or RabGDI. The employed ligation detergent (CTAB) 
was considered to be unsuitable for further purifications due to its potential 
denaturing effect, its ionic nature, its micellar size (20-30 kDa) and its low cmc value 
(ca. 1 mM), which makes it difficult to remove. Therefore, following ligation, an 
exchange of CTAB with a more appropriate additive was envisaged. For example, for 
                                                 
§§ TK, i.e. the temperature at which a detergent/solvent system passes from a hydrated crystalline state 
to an isotropic micellar solution. For most detergents this temperature is below the water freezing 
point.[269] 
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solubilization and purification of prenylated Rabs from eukaryotic membranes the 
detergents CHAPS,[270,271] sodium cholate[272] and Nonidet P-40[273] have proven to 
be useful in the past.      
The employed ligation detergent (CTAB) was only poorly capable of mediating 
solublization of the ligated and prenylated Rab proteins. Low-salt conditions resulted 
in almost quantitative precipitation of protein and peptide during the ligation, whereas 
under high-salt conditions (i.e. above 150 mM NaCl) protein and peptide were 
retained in solution. Initial purification attempts aimed at separation of the soluble 
mixture using classical biochemical techniques, such as ion-exchange, gel-filtration, 
hydroxyapatite or hydrophobic interaction chromatography. Unfortunately, none of 
these methods was capable of separating the excessive peptide from the ligated 
protein under various conditions. It appeared, that the geranylgeranylated Rab 
ligation product tightly associates with the prenylated peptide and the cationic 
detergent (CTAB, Figure 3-11A) and that neither one of the above mentioned 
methods nor more rigorous treatments, such as acetone precipitation or Triton X-114 
partitioning could weaken this interaction. Strongly denaturing reversed-phase HPLC 
with acetonitrile/TFA as a cosolvent indicated several fluorescent species 
(Figure 3-11B), which probably represent different aggregation states of the 
fluorescent peptide with protein and/or detergent.  
      
 
 
Figure 3-11: Problems associated with the purification of prenylated Rab EPL reaction products. A) 
MALDI-TOF-MS of the crude precipitate of the reaction of 2-201Rab7∆6-MESNA thioester with 
CK(Dans)C(GG)-OMe in the presence of CTAB. The ligated protein (Mcalc = 23679 Da) could be 
identified. Additional peaks probably indicate multiple adducts with cetyltrimethylammonium cations 
(Mcalc = 284 Da). Usually such noncovalent interactions can only rarely be detected during MALDI-MS 
analysis. B) HPLC analysis of the crude soluble reaction mixture using reversed-phase (C4) columns. 
Rab7∆6-MESNA thioester (1), Rab7∆6-CK(Dans)C(GG)-OMe (2), and CK(Dans)C(GG)-OMe (3) were 
identified. Other peaks (indicated by question mark) probably represent adducts between peptide, 
detergent and ligated protein. All fluorescent fractions contained significant amounts of lipidated 
peptide. 
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The association between the peptide and the ligated protein was of non covalent 
nature and presumably the result of strong hydrophobic interactions. Eventually, we 
thought of an approach which makes use of the above mentioned pronounced 
solvent incompatibility of geranylgeranylated peptides and proteins: Whereas the 
lipidated peptide was found to be excellently soluble in organic solvents, such as 
dichloromethane or methanol, but essentially insoluble in aqueous solutions, the 
lipidated protein was expected to exhibit exactly the opposite behaviour. Indeed, 
several rounds of washing of the ligation mixture or the protein precipitate with 
organic solvents, such as dichloromethane or ethyl acetate, led to quantitative 
extraction of the peptide into the organic layer (Figure 3-12). Such a treatment 
typically resulted in complete protein denaturation and aggregation, if not already 
occurred during the ligation reaction.  
The protein precipitate is insoluble in most tested solvents including methanol, 
ethanol, water or even 6 M urea. Therefore such solvents or chaotropes can be 
utilized in subsequent washing steps to remove ligation product contaminating 
detergents (CTAB), additives (MESNA) and possibly unligated protein. 
              
 
 
Figure 3-12: Separation of protein and contaminating peptide (CK(Dans)C(GG)-OMe) by repeated 
washing steps with organic solvents. Crude ligation precipitate before (lane 1) and after removal of 
excessive fluorescent peptide (lane 2). The extracted peptide (lane 3) can be re-used in another 
ligation reaction. The picture of the SDS-PAGE gel was recorded either following Coomassie-blue 
staining (A) or while illuminated with UV light (B). 
 
Using this approach peptide free ligation products could be obtained (Figure 3-12, 
lane 2). Moreover, the extracted peptide could be recovered from the combined 
organic phases and reused in another round of ligation. The inevitable problem which 
arises from the use of denaturing conditions for protein purification, however, is the 
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need for an additional resolubilization and renaturation step, which is usually 
accomplished by in vitro protein refolding.  
It is generally assumed that the folding of a polypeptide chain is a spontaneous 
process intrinsically determined by its primary structure (i.e. amino acid sequence) 
and depending on the appropriate environment. However finding the appropriate 
conditions during an in vitro refolding experiment can be a difficult task since no 
universal methods and only very few general guidelines exist.[274-276] In addition, 
some natural proteins may be completely resistant to any in vitro refolding efforts, 
which reflects the substantially different in vivo folding situation (e.g. molecular 
chaperone assisted cotranslational folding, protein folding catalysts, posttranslational 
modifications). Nevertheless, small single-domain proteins derived from total- or 
semi-synthesis or from bacterial inclusion bodies have been refolded with excellent 
yields in the past.[157,274] Small GTPases of the Ras superfamily have been 
successfully refolded recently,[277-279] but not a single study dealt with a 
posttranslationally modified protein. The presence of the C-terminal lipid(s) was 
expected to give rise to protein-misfolding due to the strong inter- or intramolecular 
interactions they could participate in (see above).  
Before starting renaturation the precipitated protein material had to be solubilized by 
strong denaturants.[280] Up to now, only solutions of 6 M GdmHCl have been found to 
efficiently solubilize the precipitated ligation product. Further additives included 
1,4-dithioerythritol (DTE) in order to keep all cysteines in the (naturally) reduced state 
and CHAPS, which was thought to promote solubilization of the geranylgeranyl lipids 
as well as to increase the refolding yields by suppressing aggregate formation.[281] 
Renaturation is usually initiated by the removal of the denaturant either by dialysis, 
dilution or column based techniques. Throughout this study pulse-renaturation by 
dilution was used, i.e. small aliquots of the denatured protein were added to the 
refolding solution after certain time intervals.[282,283] As a result, the transient 
concentration of the unfolded protein was constantly kept low, thus limiting protein 
aggregation side reactions. Typically a 1:25 dilution of the denatured protein into 
refolding solution was performed with 10 pulses over 2 h. Still, the final protein 
concentration was very low ranging from 10-100 µg/ml and required the handling of 
large volumes of refolding solutions (up to 500 ml) for preparative protein purification. 
Finally, the yield of the active enzyme recovered upon refolding did not only depend 
on the mode of renaturation and the enzyme concentration, but also critically on the 
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solvent composition.[282] For example, as pointed out above, a mild detergent 
(CHAPS) is absolutely necessary in order to mediate the solubilization of the refolded 
and lipid-modified Rab protein. In general the presence of cofactors or substrates 
(e.g. GDP or GTP) during refolding has been shown to dramatically increase the 
yields of renaturation for a number of proteins. When the protein contains disulfide 
bonds, as is the case for most secreted proteins but not for Rabs, a redox system 
has to be supplemented to the renaturation buffer.[275,284] In addition to these 
parameters, several low molecular weight compounds were empirically identified that 
can promote refolding and stabilization of the target protein.[285-287] The most 
commonly used additives are L-arginine, low concentrations of denaturants such as 
urea (1-2 M) and GdmHCl (up to 1 M), polyols (trehalose, sucrose, glycerol), and 
detergents (CHAPS, SDS, CTAB, Triton X-100). The mechanism of action of these 
additives on the folding process is largely unclear (but see for example [288]). They 
may influence both the solubility and stability of the native, denatured and 
intermediate states or they may act by changing the rates of proper folded product 
formation and the competing aggregation reaction. Due to this lack of knowledge the 
effect of a given additive on the folding of a particular protein cannot be predicted and 
must be verified for each protein. Several compounds were tested in a first screen 
either alone or in combination for their ability to promote refolding of the semi-
synthetic proteins including urea (1 M), sorbitol (10 %), sucrose (10 %), (NH4)2SO4 
(0.5 M), arginine (0.4 M), trehalose (0.4 M), ethylenglykole (20 %), CTAB (2 mM), 
dimyristoylphosphatidylcholine vesicles (DMPC, 1 mg/ml), n-octyl-β-D-glucosid (1 %), 
CHAPS (1-3 %), sodium cholate (1 %) and TX-100 (1 %).  
 
 
Figure 3-13: Optimization of the in vitro protein refolding. Different additives were screened for their 
ability to promote refolding of Rab7∆6-CK(Dans)SCSC(GG)-OMe. All reactions contained 
50 mM Hepes pH 7.5, 2.5 mM DTE, 2 mM MgCl2 and 100 µM GDP (plus residual compounds from the 
denaturing solution, i.e. 240 mM GdmHCl and 0.04 % CHAPS). Upon refolding according to the 
protocol listed in the experimental section (5.3.3.), soluble (S) and precipitated (P) proteins were 
separated by centrifugation. Aliquots were loaded on a 15 % SDS-PAGE gel followed by Coomassie 
Blue staining. 
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The efficiency of each additive was judged by determining the proportion of 
precipitated (i.e. aggregated) and soluble protein after refolding. The best condition 
identified so far was a combined usage of arginine, trehalose and CHAPS, which 
essentially completely prevented protein precipitation (Figure 3-13). Although the 
protein is maintained in the soluble fraction, this does not necessarily prove that it is 
correctly folded. Certainly, biochemical activity assays (e.g. GTP hydrolysis, or 
guanine-nucleotide binding/release) would provide a more sensitive measure for the 
functionally active state of the Rab protein. However in most cases the refolded Rab 
was intended for complexation with interacting proteins such as REP, RabGDI or 
REP:GGTase-II, which are expected to discriminate between the correctly folded and 
misfolded protein due to the dependence of this interaction on the integrity of the 
GTPase fold.[56,95,105,289] Recognition of Rab proteins by REP[111-113] or RabGDI[290] is 
dependent upon the GDP-bound conformation, which requires the presence of GDP 
during the in vitro protein refolding. On the other hand, supplementing the refolding 
buffer with other nucleotides (e.g. hydrolysis resistant or fluorescent analoges of 
GTP) could easily give access to differently loaded Rab proteins, which would meet 
the needs of various other applications.     
After renaturation of the lipid-modified Rab protein further purifications turned out to 
be straightforward using standard biochemical procedures (Figure 3-14). The Rab 
protein was complexed to either REP-1 or RabGDI and the formed complex was 
further separated from ligation and refolding additives by dialysis and gel filtration 
chromatography. The only encountered problem of the described purification 
procedure was the handling of large volumes of very dilute protein solutions, which is 
a direct consequence of the necessity for low protein concentrations during refolding. 
Hence, prior to gel filtration the protein-containing samples had to be concentrated, 
which was usually carried using time-consuming size-exclusion filtrations. Preliminary 
data indicate that concentration could more conveniently be achieved by ion 
exchange chromatography employing fast-flow columns, however, this alternative 
needs further optimization. 
The devised protocols demonstrate for the first time the applicability of the in vitro 
protein refolding approach to lipid-modified small GTPases. 
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Figure 3-14: Ligation of Rab7∆6-MESNA thioester with CK(Dans)SCSC(GG)-OMe and purification of 
the semi-synthetic Rab:REP-1 complex. Thioester tagged Rab7 (lane A), mixed with peptide (lane B) 
and following a 12 h incubation at room temperature (lane C). Excessive peptide was removed by 
washing with organic solvents (lane D). The protein was renatured, complexed to REP-1 and further 
purified by gel filtration (lane E). The 15 % SDS-PAGE gel was photographed while exposed to UV 
light (right) prior to Coomassie Blue staining (left). 
 
3.1.6. Overview of semi-synthetic protein complexes 
 
Table 3-1 summarizes the preparation results for some selected semi-synthetic 
prenylated Rab proteins which were complexed to RabGDI, REP-1, MRS6p and 
REP:GGTase-II. Various Rab proteins could be ligated to a multitude of synthetic 
peptides demonstrating that the devised protocols are generally applicable. In 
addition, the outlined purification procedure can also be adopted to the EPL semi-
synthesis of farnesylated Ras proteins (data not shown, see [291]). As will be shown in 
the following sections, most semi-synthetic Rab proteins prepared in such a manner 
displayed wild-type characteristics. In four cases however, the preparation of 
functional and stoichiometric protein complexes was unsuccessful (Table 3-1, No. 6, 
10, 11, and 15). Although the EPL and initial purifications worked as efficiently as in 
the other cases, the semi-synthetic Rab proteins could neither be complexed to 
REP-1 nor to RabGDI. Instead, following the final gel filtration chromatographic step, 
REP-1 was predominantly bound to the unprenylated and unligated Rab protein, 
whereas RabGDI largely eluted in the uncomplexed form. The ligated and prenylated 
Rab protein was retained on the column, probably in the denatured state. Such a 
behaviour was always observed when peptides bearing the dansyl fluorophore linked 
via ethylenediamine to the C-terminus were used in the EPL reaction, regardless of 
which Rab isoform was used as the thioester component.  
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Table 3-1: Selection of semi-synthetic geranylgeranylated Rab protein complexes prepared according 
to the devised protocols. * The assessment is based on complex stability and purity and on the quality 
of the analytical data (LC-ESI-MS, MALDI-MS, GF, SDS-PAGE, etc.).   
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One could interpret these findings with the inability of RabGDI or REP-1 to effectively 
accommodate the lipidated Rab C-terminus due to sterical conflicts with the non-
native reporter group. This will be discussed in view of the Ypt1:RabGDI crystal 
structure in chapter 3.4.  
In contrast, incorporation of the dansyl fluorophore into the terminal isoprenoid moiety 
does not seem to impair Rab recognition by REP-1 as judged by the co-elution of 
both proteins upon gel filtration (Figure 3-15).  
 
 
 
 
 
Figure 3-15: Ligation and purification of Rab7∆6-CESC(GG)SC(GDans)-OMe. A,B) SDS-PAGE 
analysis of the purification procedure. Rab7∆6-MESNA thioester (lane1), after ligation to the peptide 
CESC(GG)SC(Gdans)-OMe (lane 2), after removal of contaminating peptide (lane 3), and after 
complex formation with REP-1 and gel filtration purification (lane 4). The gel was photographed either 
while exposed to UV light (A) or following Coomassie Blue staining (B). C) LC-ESI-MS spectrum of the 
purified Rab7:REP-1 complex. The theoretical molecular mass of 
2-201Rab7∆6-CESC(GG)SC(GDans)-OMe is 24091 Da. D) Preparative gel filtration chromatogram of 
the Rab7:REP-1 complex utilizing a Superdex 200 (16/60) column. Calibration was carried out using 
proteins of known molecular weight (elution position indicated by arrows). Analysis of the individual 
fractions by SDS-PAGE is shown below. The lower part of the gel represents the fluorescence in the 
molecular weight range of 20-30 kDa.  
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In this context, it is important to note that complexes of Rab and REP typically elute 
as proteins of ca. 150 kDa, which is, at first glance, inconsistent with a theoretical 
molecular weight of a 1:1 complex of ca. 100 kDa. Although Shen and Seabra[117] 
argue that prenylation could induce the formation of 2:2 or 1:2 Rab:REP complexes, 
it is more likely that this discrepancy is due to an anomalous Stokes radius reflecting 
the deviation of REP from a globular shape.[105,115] Similar deviations from the 
theoretical molecular weight have been observed for RabGDI using biochemical 
techniques such as SDS-PAGE, sucrose density gradient ultracentrifugation and gel 
filtration.[56] The efficiency of ligation typically ranged from 50 % to more than 95 % 
under the devised conditions (see for example Figure 3-14 and 3-15). The final 
recovery upon complex formation and purification was usually 10-50 % with respect 
to the utilized starting Rab-thioester. The prepared complexes were highly 
homogenous, and in most cases no residual unligated Rab protein could be detected 
(but see for example Figure 3-15A). 
3.2. Characterization of the interaction of GGTase-II with single-
prenylated reaction intermediates and the doubly prenylated 
product 
 
The catalytic process by which prenyl modification of Rab proteins occurs has been 
the subject of many detailed studies in the past, since it was early recognized to be 
essential for membrane association and formation of certain specific protein-protein 
interactions.[126] Elucidation of the molecular mechanism underlying Rab double 
prenylation by GGTase-II and REP revealed a complicated process, which is 
characterized by the following features (Figure 3-16): 
1. According to the classical view, REP presents the newly synthesized Rab-GDP 
protein to GGTase-II and thereby facilitates the isoprenoid transfer.[110,114,115] Recent 
data suggest that REP-1 can also associate with GGTase-II alone in a 
phosphoisoprenoid (GGPP) dependent manner.[105,106,296] Subsequent binding of the 
Rab protein to the REP:GGTase-II:GGPP complex results in the formation of a 
prenylation competent quaternary complex (alternative pathway).     
2. The association of GGTase-II with the Rab:REP-1 complex is allosterically 
regulated by GGPP. In the absence of GGPP the double prenylated Rab:REP 
product complex is bound tighter to the GGTase-II (Kd = 2 nM)[118] than the 
unprenylated substrate complex (Kd = 120 nM).[114] To overcome this unfavourable 
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situation, binding of GGPP to GGTase-II increases the affinity of the enzyme for the 
Rab:REP substrate complex by approximately 20 fold. Conversely, the affinity for the 
double prenylated Rab:REP product is decreased by ca. 10 fold.[118] Thus GGPP 
functions as a sensor for the prenylation state of the Rab:REP complex and 
increases the enzyme´s efficiency to perform multiple catalytic turnovers. 
3. GGTase-II transfers both geranylgeranyl groups from GGPP to the C-terminus of 
Rab in two independent sequential reactions.[116,117,297] The order of isoprenoid 
addition seems to be random, i.e. in principle both cysteines can accept the 
geranylgeranyl group in the first round of prenylation. Still, one of the cysteines is 
somewhat favored but controversy remains over the exact preference.[116,117] The first 
prenyl transfer reaction appears to be faster than the second, which transiently 
results in the accumulation of single prenylated Rab reaction intermediates.[116] 
Interestingly, single prenylated Rab proteins have not been identified in vivo so far[102] 
and only little, if any, monoprenylated protein is eventually formed in in vitro 
prenylation reactions under conditions permitting multiple catalytic 
turnovers.[101,110,298] Taking into account the improper in vivo functioning of mutated 
single prenylated Rab proteins[132,133] (albeit controversial, see [134,217]), this raises the 
question by which mechanism(s) the enzyme ensures Rab double prenylation. A 
possible and very likely explanation suggests that the rate of dissociation of the 
monogeranylgeranylated Rab:REP complex from GGTase-II might be significantly 
slower than the rate of the second geranylgeranylation reaction.[116,117] 
It is noteworthy, that most studies addressing these issues employed single cysteine 
mutant proteins (i.e. in which one of the two cysteine residues had been mutated to 
serine). These mutants do not allow a clear cut answer, since changing the substrate 
structure at or near the site of the chemical transformation can be expected to 
significantly affect the kinetic behaviour of the enzyme under investigation. For 
example in analogy to FTase,[299] it seems sensible that the essential zinc ion present 
in the active site of GGTase-II coordinates to the thiolate group of the substrate 
cysteine residue and activates it for the nucleophilic attack on the C1 atom of 
GGPP.[108] In contrast, serine can be expected to coordinate much weaker to zinc, 
since hydroxyl groups are poor ligands for this metal ion.  
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Figure 3-16: Mechanism of Rab protein digeranylgeranylation. Modified from Thomä et al.[106] The 
specified rate constants (kon, koff) and dissociation constants (Kd) refer to interactions involving the 
mammalian Rab7 and REP-1 isoforms.   
 
The developed EPL strategy provides the means for elegantly circumventing these 
problems. As described in detail in chapter 3.1.1., a strategy was envisaged by which 
full length Rab7 can be generated from a C-terminally truncated N-terminal 
recombinant peptide corresponding to residues 1-201, and a synthetic C-terminal 
peptide corresponding to residues 202-207 (Figure 3-1). The Rab7 isoform was 
chosen because of its well characterized behaviour in the GGTase-II catalyzed 
prenylation reaction.[113,114,116,118,199,300] Peptides carrying a single geranylgeranyl 
group attached to either biologically relevant residue (Cys205/Cys207) as well as the 
double modified structure were synthesised by Dr. Ines Heinemann, Department of 
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Chemical Biology, MPI-Dortmund. In order to characterize the interaction between 
the semi-synthetic Rab proteins and GGTase-II, fluorophores (dansyl, NBD) linked to 
the ε-amino group of lysine were introduced by substituting the native Glu203, 
resulting in a modification that is known to be functionally tolerated (Figure 3-17).[199] 
 
 
 
 
Figure 3-17: Semi-synthesis of Rab7 proteins representing the intermediates and the product of the 
GGTase-II mediated prenylation reaction by means of EPL.  
 
Preparation of the Rab7∆6-MESNA thioester protein, its ligation to the peptides and 
the purification of the semi-synthetic protein complexed to REP-1 were carried out as 
described in chapter 3.1. and the experimental section (5.3.2. and 5.3.3.). Co-elution 
of the fluorescently labeled Rab protein(s) and REP-1 upon analytical gel filtration 
confirmed the presence of a heteromeric complex (Figure 3-18). The elution volume 
of the complexes corresponded to an apparent molecular mass of about 150 kDa. 
Taking into account the familiar unusual behaviour of REP in gel filtration 
experiments and judged by the intensity of the individual protein bands from 
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Coomassie-Blue stained SDS-PAGE gels, a 1:1 stoichiometry of the heteromeric 
complex could be inferred. 
  
 
 
Figure 3-18: A) SDS-PAGE of the purified complexes (UV = fluorescence, Coom = Coomassie 
staining). Rab7∆6-CK(Dans)SCSC(GG)-OMe:REP-1 (lane 1), Rab7∆6-CK(Dans)SC(GG)SC(GG)-
OMe:REP-1 (lane 2), and Rab7∆6-CK(Dans)SC(GG)SC-OMe:REP-1 (lane 3). B) Analytical gel 
filtration of the Rab7∆6-CK(Dans)SC(GG)SC-OMe:REP-1 complex. Column: Biosep-SEC-2000 
column (60 x 0.78 cm). Detection was based on absorbance at 280 nm (-o-) or fluorescence at 495 nm 
observed upon excitation at 340 nm (-●-). C) Preparative gel filtration of Rab7∆6-
CK(Dans)SCSC(GG)-OMe:REP-1 complex using a Superdex-200 (26/60) column. The elution position 
of standard molecular weight markers is indicated by arrows. The analysis of the individual fractions by 
SDS-PAGE is shown below. The lower part (UV) represents the gel region corresponding to 
20-30 kDa photographed in UV-light prior to Coomassie-blue staining (Coom). 
 
The identities of the prenylated Rab proteins were confirmed by detailed mass 
spectroscopic analysis (Figure 3-19). In all cases the mass of the major signal was in 
accordance with the expected molecular masses of the ligated Rab proteins 
(± 15 Da, which is within the error range of the MALDI spectrometer). Only little, if 
any, unligated Rab protein could be detected by MALDI-MS spectroscopy, 
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SDS-PAGE (see for example Figure 3-14) or RP-HPLC. These data suggest that the 
prepared Rab proteins are homogenously prenylated and are able to form 
stoichiometric complexes with REP-1 indicating a native GTPase fold. 
  
 
 
Figure 3-19: MALDI-MS analysis of semi-synthetic Rab:REP-1 protein complexes. 
2-201Rab7∆6-MESNA thioester (before ligation, Mcalc = 22932 Da) is shown in blue. A) 
2-201Rab7∆6-CK(Dans)SCSC(GG)-OMe (Mcalc = 23939 Da). The inset shows the range from 60-80 kDa 
and the signal corresponding to REP-1 (Mcalc = 73475 Da). B) 2-201Rab7∆6-CK(Dans)SC(GG)SC-OMe 
(Mcalc = 23939 Da), C) 2-201Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe (Mcalc = 24212 Da), and 
D) 2-201Rab7∆6-CK(NBD)SCSC(GG)-OMe (Mcalc = 23870 Da). The deviation of the observed molecular 
masses from the calculated values is within the error range of the mass spectrometer. Matrix: sinapinic 
acid. 
 
To further confirm the functionally active state of the complexes, their competence to 
act as a substrate in the prenylation reaction was investigated using an established 
assay.[301] The individual Rab:REP-1 complexes were incubated with GGTase-II and 
tritium labeled geranylgeranylpyrophosphate ([3H]-GGPP). After completion of the 
reaction (30 min), proteins were precipitated with ethanol/HCl and separated from 
excessive [3H]-GGPP by filtration through glass-fiber filters. The amount of 
radioactivity incorporated into the proteinaceous material was determined by 
scintillation counting (Figure 3-20). Wild-type Rab7 protein incorporated twice as 
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much radioactivity than the single prenylated semi-synthetic 
Rab7∆6-CK(Dans)SCSC(GG)-OMe protein and a Rab7 mutant lacking one of the 
prenylateable cysteines (Rab7C205S). These data suggest that the single prenylated 
protein could function as an acceptor for another geranylgeranyl group. Similar 
results were obtained for the other single prenylated proteins (Figure 3-20B). The 
unprenylated cysteine is therefore fully accessible indicating that the in situ 
deprotection of the StBu-protected cysteines during the ligation reaction was 
essentially quantitative. This is also in agreement with the mass spectroscopic data. 
The double prenylated semi-synthetic Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe 
protein incorporated significantly lower amounts of radioactivity than the single 
prenylated proteins, still slightly more than the negative control without GGTase-II 
(Figure 3-20B, lane 3 and 5). Although the significance of this observation is not clear 
yet, one could speculate that GGTase-II could transfer an additional prenyl group to 
the third (ligation-) cysteine (Cys202), albeit with much lower efficiency. Triple 
prenylated Rabs have neither been identified in vitro nor in vivo, but this could simply 
be due to the fact, that Rabs possessing three prenylateable cysteines within their 
last six amino acids naturally do not exist. 
   
 
 
Figure 3-20: Incorporation of [3H]-geranylgeranyl into the semi-synthetic proteins catalyzed by 
GGTase-II. A) Prenylation of Rab7∆6-CK(Dans)SCSC(GG)-OMe (lane 1, 2) in the absence (lane 1) 
and presence (lane 2) of GGTase-II. Rab7wt (lane 3) and the single cysteine mutant Rab7C205S 
(lane 4) are shown for comparison. B) Prenylation of Rab7∆6-CK(Dans)SCSC(GG)-OMe (lane 1), 
Rab7∆6-CK(Dans)SC(GG)SC-OMe (lane 2), Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe (lane 3), and 
Rab7∆6-CK(NBD)SCSC(GG)-OMe (lane 4). Lane 5 represents the negative control (Rab7wt in the 
absence of GGTase-II). All reactions contained 50 pmol [3H]-GGPP (15000 cpm/pmol), 11 pmol of the 
corresponding Rab7:REP-1 complex and 10 pmol of mammalian GGTase-II, unless otherwise 
indicated. 
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For quantitative analysis of the interaction of RabGGTase with the single prenylated 
reaction intermediates and the doubly prenylated product, a fluorescence assay was 
employed. Excitation and emission scans of the semi-synthetic Rab7:REP-1 protein 
complexes indicated that dansyl fluorescence could be excited either directly at 
340 nm or via Fluorescence Resonance Energy Transfer (FRET) from tryptophan at 
280 nm. Upon interaction with GGTase-II, an increase in the dansyl fluorescence was 
observed. When the dansyl fluorophore was excited via FRET at 280 nm the 
interaction resulted in an at least 300 % increase in fluorescence at around 500 nm 
(see Figure 3-22), whereas direct excitation of the dansyl fluorophore at 340 nm gave 
only a minor fluorescence increase of around 5% (not shown, but see for 
example [118]). 
 
 
Figure 3-21: Emission scans of GGTase-II (-⋅⋅-) and Rab7∆6-CK(Dans)SC(GG)SC-OMe:REP-1 (--) 
alone and upon ternary complex formation (⎯). The concentration of each component was 200 nM 
and excitation was at 280 nm. 
 
The change in fluorescence upon interaction is proportional to the amount of ternary 
Rab7:REP-1:GGTase-II complex formed, and can be utilized to determine the 
equilibrium constant of the interaction of Rab:REP with GGTase-II. Titrating small 
aliquots of GGTase-II to a solution of the individual Rab7:REP-1 complexes revealed 
that the change in fluorescence is saturable (Figure 3-22). However, addition of 
GGTase-II resulted also in an unspecific increase in fluorescence due to the 
increased concentration of tryptophan residues (mammalian GGTase-II contains a 
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total of 20 Trp-residues). This unspecific fluorescence increases linearly with 
increasing concentrations of GGTase-II, which usually becomes evident when the 
titration curve approaches saturation (Figure 3-22B). The contribution of the 
unspecific fluorescence can be determined by linear regression and allows for 
correction of the binding data (Figure 3-22C). 
 
 
Figure 3-22: A) Fluorescence titration of ca. 100 nM Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe:REP-1 
complex with increasing concentrations of GGTase-II. At each breakdown of the fluorescence signal 
another portion of GGTase-II was added to the cuvette. B) The observed fluorescence was plotted as 
a function of the GGTase-II concentration. The straight line represents the increase in unspecific 
tryptophan fluorescence due to the addition of GGTase-II. The slope was used for data correction. C) 
Corrected titration data. The solid line represents a fit to the binding equation with a Kd of 14±1 nM. D) 
Displacement of the semi-synthetic fluorescently labeled Rab7:REP-1 complex from GGTase-II by 
addition of 1 µM of doubly prenylated, wild type Rab7:REP-1 complex. The solid line represents a fit to 
a single exponential equation yielding a koff of 0.017±0.001 s-1. The signal was based on FRET, 
exciting at 280 nm, while emission was observed at 495 nm. 
 
The titration curves obtained from the equilibrium binding experiments were 
evaluated assuming a 1:1 stoichiometric binding mode for the interaction of 
GGTase-II with the Rab7:REP-1 complexes. The fluorescence (F) observed after 
each step of GGTase-II addition is then described by the following equation: 
[ ] [ ] [ ] [ ]( ) [ ] [ ]{ } [ ]0 minmax0020000min 24 P FFLPPLKPLKFF dd −−++−+++=  
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where [L]0 and [P]0 refer to the total concentrations (free and bound) of ligand 
(L, corresponding to [GGTase-II]) and  protein (P, [Rab7:REP-1 complex]), 
respectively. Fmin represents the fluorescence at [L]0 = 0, Fmax is the fluorescence at 
saturation (i.e. [L]0 → ∞) and Kd is the dissociation constant that is to be determined. 
The derivation of this equation is described in more detail in the Appendix section 
7.1.1. A least-squares fit of the obtained binding isotherms to this equation allowed 
estimation of Kd (Figure 3-22C). It is noteworthy, that under certain conditions 
(namely when [P]0 >> Kd) the curves additionally provide reliable information 
concerning the stoichiometry of the interaction. In this case the curve resembles a 
rectangular hyperbola with a well defined turning point, which indicates the ligand 
concentration required for full occupation of the binding sites (see Figure 8-1). For 
example, inspection of the binding curve in Figure 3-22C reveals, that addition of 
approximately 100 nM GGTase-II is sufficient to saturate all binding sites on the 
Rab7:REP-1 complex. Since the concentration of the titrand was ca. 100 nM, it can 
be inferred that the stoichiometry of the interaction is 1:1. 
            
 
Figure 3-23: A) Fluorescence titration of 150 nM Rab7∆6-CK(Dans)SC(GG)SC-OMe with GGTase-II. 
The solid line represents a fit to the binding equation yielding a Kd of 35±4 nM. The inset displays the 
original data (at each breakdown of the fluorescence signal another portion of GGTase-II was added 
into the cuvette). B) Displacement of the semi-synthetic complex from GGTase-II (each 150 nM) by 
addition of 1.4 µM doubly prenylated, wild type Rab7:REP-1. The solid line represents a fit to a single 
exponential equation with a dissociation rate constant koff of 0.024±0.001 s-1. The signal was based on 
FRET. Excitation was at 280 nm, while data were collected at 495 nm.  
 
Reversal of the titration, i.e. titrating GGTase-II with increasing amounts of 
Rab7:REP-1 complex, produced comparable curves with essentially the same 
dissociation constants.[292]  
The change in energy transfer observed upon interaction of the dansyl labeled 
Rab7:REP-1 complexes with GGTase-II can also be used to monitor the kinetics of 
 3. Results and Discussion 61 
 
the reaction. The dissociation rate constants of the interaction were determined by 
displacement experiments. When the dansyl labeled Rab7:REP-1:GGTase-II 
complex is mixed with a large excess of fluorescently silent doubly prenylated 
Rab7:REP-1 complex, the observed time-trace describes the dissociation of the 
labeled complex (Figure 3-22D). The obtained curve can be fitted to a single 
exponential equation yielding a rate constant, which under the employed conditions 
corresponds to the rate constant of the dissociation reaction (koff, see Appendix 
7.1.2.).  
 
 
Figure 3-24: A) Fluorescence titration of 100 nM Rab7∆6-CK(Dans)SCSC(GG)-OMe with GGTase-II. 
The solid line represents a fit to the binding equation yielding a Kd of 7±2 nM. B) Displacement of the 
semi-synthetic complex from GGTase-II by addition of 1.2 µM doubly prenylated wild type 
Rab7:REP-1. The fit shown is to a single exponential with a rate constant koff of 0.027±0.001 s-1. The 
signal was based on FRET. Excitation was at 280 nm, while data were collected at 495 nm. 
 
The obtained dissociation constants and rate constants are summarized in Table 3-2 
and are in good agreement with known literature values. Prenylation of Rab7:REP-1 
results in a 3-15 fold higher affinity for GGTase-II when compared to the 
unprenylated protein. Both monoprenylated reaction intermediates are therefore 
tightly bound to GGTase-II. Interestingly, Rab7:REP-1 complex prenylated only on 
the internal cysteine residue (Cys205, Kd = 35 nM) displayed a 3-5 fold decrease in 
affinity for GGTase-II as compared to the C-terminally monoprenylated (Cys207, 
Kd = 7 nM) and doubly prenylated (Kd = 13 nM) complexes.  
The position of the Rab C-terminus in the ternary Rab:REP:GGTase-II complex is not 
known. Structure based modeling studies suggest that the unprenylated C-terminus 
is transferred to the GGTase-II upon interaction.[105] The C-terminus of single 
prenylated Rabs must be positioned near the active site of GGTase-II in order to be 
accessible for the second prenyl transfer reaction, since the large distance between 
the transferase active site and REP preclude a situation in which the conjugated 
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isoprenoid is bound to REP, while the adjacent cysteine protrudes into the active 
site.[105] Moreover, biochemical[116,118] and modeling[299] data indicate, that 
geranylgeranyl moieties attached to the Rab protein do not occupy the 
phosphoisoprenoid binding site at the active site of the transferase, but could be 
positioned in a nearby hydrophobic tunnel, patch or binding pocket.[299] It is 
conceivable that crucial functional groups mediating the interaction of the 
monoprenylated Rab C-terminus with GGTase-II involve the unprenylated cysteine 
residue (coordinated to the zinc ion) and the conjugated isoprenoid moiety.  
Hence, the observed significant differences in affinities of the monoprenylated 
complexes for GGTase-II could be attributed to the different location of the 
unprenylated cysteine residue and the prenyl group attached to the other cysteine. In 
fact, these are the only structural features that distinguish these complexes. 
Following this line of argumentation, positioning of the prenyl group on the upstream 
cysteine (Cys205) could impose an unfavorable orientation of Cys207, which is 
reflected by the larger dissociation constant of the interaction. Conversely, 
accommodation of the isoprenoid attached to the C-terminal cysteine and 
coordination of Cys205 to the zinc ion is prefered, which might explain the observed 
preference of GGTase-II for the terminal cysteine in the first round of prenylation.[116] 
 
Complex Kd [nM] koff [s-1] 
Rab7∆6-CK(Dans)SCSC-OH:REP-1[199,300] 111 - 
Rab7∆6-CK(Dans)SCSC(GG)-OMe:REP-1 7 ± 2 0.027 ± 0.001 
0.017 ± 0.001 * 
Rab7C205S;C207C(GG):REP-1[116] ~ 1 0.010 
Rab7∆6-CK(Dans)SC(GG)SC-OMe:REP-1 35 ± 4 0.023 ± 0.001 
Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe:REP-1 13 ± 1 0.019 ± 0.001 
Rab7∆6-CK(Dans)SC(GG)SC(GG)-OH:REP-1[118] 2 0.017 
Table 3-2: Interaction of GGTase-II with unprenylated Rab7:REP-1, single prenylated reaction 
intermediates and doubly prenylated product as described by the dissociation constants (Kd) and the 
rate constants of the dissociation step (koff). The values are the mean and the standard error of at least 
three independent measurements. For the sake of comparison, values from the literature were 
incorporated into the table and are marked by the corresponding references. The values were 
determined at T = 25° C (* 20° C). 
 
The dissociation rate constants (koff) are essentially identical in case of the 
monoprenylated complexes, indicating that the differences in affinity must be due to a 
difference in the association rate constants. Moreover, the dissociation rate constants 
of the single prenylated reaction intermediates were found to be lower than the 
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second prenylation step (k = 0.04 s-1 [116]), suggesting that dissociation is not 
obligatory for double prenylation of Rab proteins.  
The known impact of GGPP on the affinities of GGTase-II for its unprenylated 
substrate and doubly prenylated product (see above)[118] raises the question whether 
the interaction with the single prenylated reaction intermediates is influenced by 
GGPP or not. Studies employing single prenylated cysteine mutant proteins indicate 
that the dissociation rate constant is essentially unaffected by the presence of 
GGPP.[116] Unfortunately, comparable studies using the obtained semi-synthetic 
Rab:REP complexes could not further address this question, since as expected, 
addition of GGPP to the single prenylated ternary complexes is sufficient to initiate 
the second prenyl transfer reaction (Figure 3-20). In this context, GGPP analogs in 
which the ester moiety is replaced by an enzymatically inert functionality could prove 
useful in the future (Figure 3-25). Such compounds cannot be catalytically transferred 
onto Rab proteins, while it is likely that their binding to GGTase-II is more or less 
unimpaired. 
 
Figure 3-25: GGPP and derivatives thereof, wich cannot be transferred by GGTase-II. 
GGPP = geranylgeranylpyrophosphate, GGcPP = geranylgeranylmethylphosphonylphosphate, 
GGcPcP = geranylgeranylmethylphosphinylmethylphosphonate. 
3.3. A sensitive, real-time fluorescence based prenylation assay 
 
The competence of the single prenylated semi-synthetic Rab proteins to accept 
another isoprenoid group by GGTase-II catalysis inspired us to check whether the 
transfer of the prenyl group can be observed by fluorescence changes of the dansyl 
reporter group. The proximity of the fluorophore to the prenylation site as well as the 
known sensitivity of dansyl toward environmental changes can be assumed to 
provide a sensitive measure for the prenylation state of the Rab C-terminus and 
should allow to follow the prenylation reaction in real-time. 
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When the single prenylated Rab7:REP-1 complexes (ca. 75 nM) were mixed with 
equal amounts of transferase, formation of the ternary complex could be inferred 
from the strong fluorescence increase observed at 510 nm upon excitation at 
280 nm. The concentrations of the individual components were chosen based on the 
obtained Kd values (section 3.2.). Under such conditions the Rab:REP:GGTase-II 
complex can be expected to be the predominant species, since the concentrations of 
all proteins are far above the respective Kd value. The enzyme is only capable of 
performing a single turnover, since neither REP-1 nor GGTase-II are limiting factors. 
Addition of GGPP (10 µM) instantly resulted in a decline of the fluorescence signal. 
The observed reaction was essentially completed within 10 min and the obtained 
time traces could be fitted to a double exponential equation (Figure 3-26A). Under 
the same conditions, the observed changes of the fluorescence amplitude were in 
case of the single prenylated Rab substrates significantly larger than for the doubly 
prenylated Rab protein (Figure 3-26A). The low fluorescence change observed in 
case of the latter possibly represents low efficiency transfer of a third prenyl group 
onto the ligation cysteine, which is also in agreement with results presented earlier 
(Section 3.2. and Figure 3-20).  
 
 
Figure 3-26: A) 75 nM of either Rab7∆6-CK(Dans)SCSC(GG)-OMe (blue), Rab7∆6-
CK(Dans)SC(GG)SC-OMe (red) or Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe (green) in complex with 
REP-1 were incubated with 75 nM GGTase-II. At the moment indicated by arrows 10 µM GGPP was 
added. B) Fluorescence changes seen upon mixing 75 nM Rab7∆6-CK(Dans)SCSC(GG)-
OMe:REP-1:GGTase-II with 10 µM GGPP in the absence (blue) and presence (red) of 500 µM 
inhibitor NE10790. Excitation and emission monochromators were set to 280 nm and 510 nm, 
respectively. The colored curves represent fits to a double exponential equation. The individual rate 
constants are summarized in Table 3-3. 
 
In order to further confirm that the observed reaction reflects the second prenyl 
transfer reaction, the experiment was repeated in the presence of a known 
GGTase-II inhibitor. NE10790 is a phosphonocarboxylate-based inhibitor specific for 
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GGTase-II and prevents Rab prenylation when present in high micromolar 
concentrations (IC50 ~ 600 µM).[302] Addition of this compound (500 µM) to the in vitro 
prenylation reaction significantly slowed down the rate of fluorescence decrease, 
suggesting that the observed reaction indeed represents the catalytic prenylation 
step (Figure 3-26B). Interestingly, upon pre-incubation of GGTase-II with the inhibitor 
and initiation of the reaction by addition of GGPP, the initial progression of the 
reaction was significantly delayed. This lag-phase (Figure 3-26B) might be attributed 
to a (slow) displacement of the inhibitor by GGPP, suggesting that both compounds, 
at least partially, have a common binding site on the enzyme. The structural similarity 
between the phosphonocarboxylate functionality and the pyrophosphate structure of 
GGPP seems to support this notion. A possible candidate site could be the basic 
cluster previously identified in the GGTase-II structure, which has been proposed to 
bind the GGPP head-group.[108] 
The observation that the obtained time traces can only be described by double 
exponential equations indicates that the process on the molecular level is composed 
of at least two steps, which give rise to fluorescence changes. This seems sensible, 
because the reaction is not only composed of the phosphoisoprenoid binding and 
catalytic transfer step, but presumably also comprises rearrangement and 
isomerization steps in the active site as well as pyrophosphate release and transfer 
of the Rab C-terminus onto REP. The obtained rate constants are summarized in 
Table 3-3. 
 
Substrate k1 [s-1] k2 [s-1] Kd [nM]* 
Rab7∆6-CK(Dans)SCSC(GG)-OMe 0.047 0.004 7 ± 2 
Rab7∆6-CK(Dans)SCSC(GG)-OMe + 
500 µM NE10790 
0.005 0.002 - 
Rab∆6-CK(Dans)SC(GG)SC-OMe 0.012 0.002 35 ± 4 
Rab7∆6-CK(Dans)SC(GG)SC(GG)-OMe 0.015 0.001 13 ± 1 
Table 3-3: Rate constants obtained from in vitro prenylation reactions under single turn-over 
conditions. The concentrations of GGTase-II, REP-1 and Rab substrate were approximately 75 nM. 
GGPP concentration was 10 µM (T = 25° C). k1 and k2 represent the obtained rate constants of the 
fast and slow phases, respectively. * Refers to the observed dissociation constant of the interaction of 
the corresponding Rab7:REP-1 complexes with GGTase-II (from Table 3-2). 
 
The rate constants of the fast phase (k1) are in excellent agreement with values 
previously reported in the literature for the second prenyl transfer reaction: On the 
basis of a HPLC assay, Thomä et al. estimated the rate constant of the second 
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prenyl transfer reaction as 0.04 s-1 using Rab7∆6-CK(Dans)SCSC-OH as a 
substrate.[116] Studies employing the traditional in vitro prenylation assay that 
measures the incorporation of [3H]-geranylgeranyl into proteins, allowed the 
determination of steady-state parameters of the double prenylation reaction, yielding 
a kcat of ca. 0.03 s-1 for various Rab substrates.[115]  
These data strongly support the presumption, that the observed fluorescence 
changes are directly or indirectly linked to the second isoprenoid transfer reaction, 
which can be described by the rate constant of the fast phase (k1). The data from 
Table 3-3 indicate, that the second prenylation of the upstream cysteine (Cys205) is 
approximately 4 times faster compared to the prenylation of the terminal Cys207. 
Apparently, the tighter bound single prenylated reaction intermediate is also faster 
converted to the doubly prenylated product. This could be rationalized in view of the 
discussion regarding the observed differences in affinities of the single prenylated 
Rab7:REP-1 complexes for GGTase-II presented in section 3.2. One could argue, 
that binding of the first geranylgeranyl group to GGTase-II influences the fixation of 
the unprenylated cysteine in the active site and that this different orientation accounts 
for the observed differences in affinities. Interaction of the cysteine with the active site 
of GGTase-II probably involves the essential zinc ion, which activates the thiol group 
for the nucleophilic attack on the C1 of GGPP (stabilization of the thiolate form 
decreases the cysteine´s sulfhydryl pKa and increases its nucleophilicity). It is 
conceivable that stronger stabilization (stronger binding, lower Kd value) results in 
stronger activation of the cysteine (higher reactivity, faster prenyl transfer). This could 
explain, that in the examined cases the affinities of the reaction intermediates for 
GGTase-II are directly related to their ability to accept the second prenyl group. 
However, it is important to keep in mind, that the precise rate-determining step of the 
molecular reaction is not necessarily the enzymatic transfer step. Other steps, either 
preceeding or following the nucleophilic substitution reaction could as well be 
influenced by the different prenyl pattern or by a different orientation of the 
conjugated isoprenoids in the active site.      
The known rate constants for the first and the second prenylation reaction are 
summarized in Figure 3-27. From these, one could conclude, that the majority of 
Rab7 proteins proceeds to double prenylation by first acquiring prenylation on the 
C-terminal cysteine, followed by modification of the upstream cysteine.[116] However, 
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taking into account the heterogenous nature of Rab prenylation motifs, the 
preference of GGTase-II could be different for other Rabs.[117,217]  
 
 
 
Figure 3-27: Rate constants describing the Rab7 double prenylation reaction under saturating 
concentrations of REP-1, GGTase-II, Rab7, and GGPP. The rate constants of the first prenyl transfer 
(kA and kA´) were determined by employing single cysteine mutant proteins (lower limit). The upper 
limit refers to the value determined by analyzing the prenylation of Rab7wt protein (dansyl labeled), 
which leads transiently to the accumulation of single prenylated proteins (since kA > kB).[116] The kB 
values were determined in this study and represent the k1 values of Table 3-3.  
 
3.4. The molecular basis of Rab:RabGDI interaction 
 
REP and GGTase mediate the crucial posttranslational modification of all known 
Rabs, and thus are essential general regulators of Rab protein functioning. Another 
well known regulatory protein factor that seems to act on all Rab GTPases[303,304] is 
Rab GDP dissociation inhibitor (RabGDI), which exhibits numerous biochemically 
well defined functions.[305] RabGDI binds exclusively to the geranylgeranylated and 
GDP bound form of Rab proteins,[126,306] and slows the dissociation of GDP from the 
GTPase.[56] RabGDI also facilitates the extraction of inactive (i.e. GDP bound) Rab 
proteins from membranes by forming stoichiometric complexes[57] and subsequently 
delivers them to defined compartments,[60,61] thus ensuring specific Rab recycling 
(Rab cycle, see Figure 1-2). As discussed in the introductory chapter, efficient Rab 
shuttling between membranes requires additional membrane bound factors, termed 
RRF and GDF. 
The molecular basis of some of the aspects of RabGDI functioning has previously 
been adressed by structural and mutational studies (reviewed by [307]). RabGDI is 
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composed of two domains, a large (ca. 340 AA) domain I, and a smaller (100 AA), 
entirely α-helical domain II (Figure 3-28).[308] Mutational analysis identified a highly 
conserved region at the apex of domain I, that plays a critical role in the binding of 
Rab proteins (Rab binding platform).[58,125] A second region located between domain I 
and II has been implicated in the extraction of membrane-bound Rab proteins and 
probably mediates the interaction of RabGDI with the putative membrane bound 
receptors (termed mobile effector loop, MEL).[59,309] 
   
 
 
Figure 3-28: Ribbon representation of the structure of bovine α-RabGDI at 1.04 Å resolution (PDB 
entry code: 1D5T).[309] The protein is composed of two domains. Domain I is colored light-blue, domain 
II is colored violett. The Rab-binding platform (yellow) and the mobile effector loop (red) are 
highlighted. 
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However, the available structures of apo-RabGDI[58,308] cannot provide a structural 
explanation for the observed RabGDI activities mentioned above. A more detailed 
structural analysis is required in order to achieve a molecular understanding of 
RabGDI functioning. Ideally, this should include the elucidation of the binary 
Rab:RabGDI complex structure, to further characterize the specific interactions 
between the prenylated Rab and RabGDI. Although this structure has been eagerly 
awaited (e.g. [310]), little progress was made in this direction probably due to problems 
associated with the expression and purification of prenylated Rabs. Classical 
procedures, such as expression in eucaryotic cells,[270,271] purification from animal 
tissues[272,311] or in vitro prenylation,[312,313] typically suffer from low yields, a difficult 
purification procedure and high costs, precluding the production of homogenously 
prenylated Rabs in large amounts. The developed EPL strategy could alternatively 
be employed to circumvent these problems. As was demonstrated in the previous 
sections, the reaction is capable of generating homogenously prenylated Rab 
proteins. The reaction and subsequent purification steps can be anticipated to be 
adjustable to multi-milligramm amounts of protein, typically required for extensive 
crystallization trials, provided that the Rab-thioester and the prenylated peptide are 
readily accessible. As shown in Table 3-1, a number of prenylated Rab:RabGDI 
complexes were envisaged for EPL semi-synthesis utilizing the described protocols 
(complexes No. 2, 9, 11, 12, 15, and 16 from Table 3-1). These complexes are 
composed of different Rab family members (e.g. Rab7, Ypt7, Ypt1), which comprised 
C-terminal deletions of various length (∆2 to ∆7) and were ligated to various peptides. 
Since mono-geranylgeranylated Rabs can also complex to RabGDI,[303,314,315] the 
peptide part could be designed to carry either a single or both geranylgeranyl 
moieties.  
RabGDI also does not strictly require C-terminal carboxyl-methylation for efficient 
interaction with Rab proteins,[306,315] suggesting that C-terminally modified as well as 
unmodified peptides could be used for ligation and subsequent complex formation. 
Some of the peptides contained fluorophores, which easily allowed tracking of the 
ligated protein during purification experiments; a tool that proved especially useful in 
the early stages of the project. The peptides were synthesised by members of the 
Waldmann lab, Department of Chemical Biology, MPI-Dortmund (see Table 5-1 for 
details). Ligation of the various Rab proteins to the different peptides was efficient, 
typically giving ligation yields of at least 70 % (often > 95 %) with respect to the 
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utilized Rab-thioester under the described conditions (Chapter 3.1.). Unfortunately, 
semi-synthetic and in vitro refolded Rab proteins containing the dansyl fluorophore 
linked to the C-terminus (No. 11 and 15 from Table 3-1), failed in forming any 
detectable complex with RabGDI, as could be inferred from gel filtration experiments, 
SDS-PAGE and mass spectroscopic analysis. These Rabs also failed to interact with 
the REP-1 protein (chapter 3.1.5.). At the simplest level of interpretation, this could 
be explained with the considerably increased bulkiness of the dansyl fluorophore as 
compared to the tolerated methylester, which could sterically interfere with the 
accommodation of the Rab C-terminus on REP and RabGDI. Given the conserved 
structure and function within the RabGDI/CHM family,[105,307,308,310] it seems plausible 
that both REP and RabGDI utilize a similar mode of interaction with the Rab 
C-terminus, that is in both cases affected by the aforementioned modification.  
The succesfully obtained complexes (No. 2, 9, 12, and 16, Table 3-1) were further 
utilized for crystallization trials, which were carried out by Dr. Alexey Rak, 
Department of Physical Biochemistry, MPI-Dortmund. Eventually, two of these 
complexes, namely the single and doubly prenylated Ypt1:RabGDI complex, could be 
crystallized. The diffraction data were collected to 1.5 and 1.4 Å resolution, 
respectively.  
3.4.1. The structure of monoprenylated Ypt1 in complex with 
RabGDI 
 
Single prenylated Ypt1∆2-CC(GG) in complex with yeast RabGDI was prepared in a 
total amount of ca. 20 mg in a single ligation and purification setup, as described 
before, which corresponds to 7-8 mg of semi-synthetic Ypt1 GTPase. The final 
recovery yield of Ypt1 protein was ca. 50 %. The identities of the individual proteins 
were verified by MALDI-MS and LC-ESI-MS analysis (Figure 3-29A, B, D) and only 
very little, if any, unligated Ypt1 protein could be detected. The produced complex 
appeared to be of excellent purity as could be inferred from SDS-PAGE experiments 
(Figure 3-29C).  
Furthermore, gel filtration experiments confirmed the critical importance of the 
geranylgeranyl moiety for the interaction of Ypt1 with RabGDI (Figure 3-30B). When 
a mixture of Ypt1∆2-MESNA thioester and RabGDI was applied to a gel filtration 
column, separate elution of both components was observed, whereas the semi-
synthetic complex eluted as a single symmetric peak. 
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Figure 3-29: Preparation of the Ypt1∆2-CC(GG):yRabGDI complex. A) LC-ESI-MS spectrum of 
1-204Ypt1∆2-MESNA thioester (Mcalc = 23131 Da) and of B) 1-204Ypt1∆2-CC(GG) (Mcalc = 23486 Da). 
C) SDS-PAGE gel of the obtained semi-synthetic Ypt1∆2-CC(GG):yRabGDI complex after gel filtration 
(lane 1). Yeast RabGDI (lane 2) and Ypt1∆2-MESNA thioester (lane 3) are shown for comparison. 
Arrows indicate the migration of yRabGDI (a) and Ypt1 (b). D) MALDI-TOF-MS of the semi-synthetic 
complex. The theoretical molecular mass of yRabGDI is 51401 Da. The discrepancy of the determined 
values for the Ypt1∆2-CC(GG) protein measured by ESI-MS (B, 23484 Da) and MALDI-MS (D, 
23521 Da), is due to the inaccuracy of the MALDI spectrometer. 
  
In case of the latter, the observed elution time corresponded approximately to a 
molecular weight of 80 kDa indicating the presence of a 1:1 Ypt1:RabGDI complex. 
Thus, a single prenyl group is sufficient to confer binding of Ypt1 to RabGDI, which is 
in agreement with previous observations.[303,314,315] From these experiments one 
could also conclude, that the obtained complex is indeed homogenously prenylated, 
since no residual unligated Ypt1 thioester could be detected. Crystallization, 
determination of the initial phases by molecular replacement, model building and 
refinement, and the final analysis of the structure were carried out by Dr. Alexey Rak, 
Dr. Olena Pylypenko and Dr. Kirill Alexandrov, Department of Physical Biochemistry, 
MPI-Dortmund (for details see [295]). The obtained 1.5 Å resolution model is presented 
in Figure 3-31. 
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Figure 3-30: A) Crystals of Ypt1∆2-CC(GG):yRabGDI obtained by Dr. Alexey Rak (Department of 
Physical Biochemistry, MPI-Dortmund). For details of the crystallization conditions see [295]. 
B) GF-HPLC analysis of the Ypt1∆2-CC(GG):yRabGDI complex. The elution time of the binary 
complex (1), of monomeric yRabGDI (2) and Ypt1∆2-MESNA thioester (3) are indicated. 
 
The GTPase domain of Ypt1 binds primarily to RabGDI by forming contacts with the 
previously identified Rab-binding platform of RabGDI.[58,308] On the part of Ypt1 this 
interaction involves the switch I and II regions, that function as conformational 
sensors for the GDP and GTP nucleotide bound state of GTPases.[75-77] Contacts 
between the switch regions and the Rab-binding platform are therefore expected to 
be responsible for the observed preference of RabGDI for the GDP bound 
conformation of Rab proteins (see below). The Rab binding platform as well as the 
switch regions are highly conserved within their respective protein families and 
among different species, which allow a relatively low number of RabGDI isoforms*** to 
interact with all of the more than 60 Rab proteins.   
                                                 
*** At least three RabGDI isoforms were identified in mammalian organisms (for nomenclature 
see [307]), which exhibit largely the same biochemical activities mentioned above. Still, the specific 
localization of certain RabGDI isoforms to distinct tissues or subcellular compartments as well as their 
functional specificity for a certain subset of Rabs seem to suggest a specialized functional role for 
each isoform.[316-318]  
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Figure 3-31: Ribbon representation of the structure of the semi-synthetic, single prenylated 
Ypt1:RabGDI complex at 1.5 Å resolution. Ypt1 (light red), the RabGDI domains I (light blue) and II 
(violett), the Rab-binding platform (yellow), the C-terminus binding region (CBR, green), the mobile 
effector loop (MEL, red), and the Mg2+-ion (blue sphere) are indicated. The geranylgeranylated 
C-terminal cysteine residue 206 of Ypt1 and the bound nucleotide are shown in stick representation in 
atomic colors. The residues 199 to 205 of Ypt1, which are located directly upstream of Cys(GG)206, are 
disordered and were modeled into the structure. Reproduced from Rak et al.[295] 
 
Additional important contacts between both molecules are established by interactions 
involving the last 20 C-terminal amino acid residues of Ypt1 including the 
hydrophobic isoprenoid. This region passes from the apex of RabGDI domain I down 
to the domain II in a extended conformation and terminates at a hydrophobic pocket 
harboring the geranylgeranyl moiety. The Ypt C-terminus is held in place by forming 
a number of interactions with surface exposed residues of RabGDI, including the 
mobile effector loop (Figure 3-32). A second region, termed C-terminus binding 
region (CBR) is located above the MEL, and appears to induce a 90° turn in the 
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C-terminus directing it toward the lipid-binding site of domain II. The importance of 
this patch for efficient coordination of the Rab C-terminus to RabGDI is supported by 
the finding, that a number of mutations impairing Rab membrane extraction or 
delivery localize to this region. For example, mutation of Thr105 of yeast RabGDI to 
alanine is associated with defective Rab membrane delivery leading to accumulation 
of Rab:RabGDI in the cytosol.[319] In contrast, substitution of Ile92 by proline in 
mammalian α-RabGDI (corresponding to Ile100Pro in yeast RabGDI) reduces the 
ability of RabGDI to extract Rabs from membranes increasing the membrane-bound 
pool of the protein.[320] The latter RabGDI mutation in humans has been linked to one 
form of X-linked non-specific mental retardation (MRX), a disorder that severly 
impairs the intellectual and learning abilities of affected males.[320] The Ile92Pro 
mutation could potentially lead to significant structural changes in RabGDI, since Ile92 
is part of helix C and proline is a notorious helix-breaker.  
 
 
 
Figure 3-32: Interaction of the Ypt1 C-terminus with RabGDI. Ypt1 is displayed in ribbon 
representation (light red) whereas RabGDI is shown in surface representation (turquoise). CBR 
(green), MEL (red) and the lipid-binding pocket (blue) interact with the last 20 amino acid residues of 
Ypt1. The second isoprenoid is possibly bound to a hydrophobic groove in proximity to the identified 
isoprenoid binding pocket (indicated by a box). The locations of isoleucine100 and threonine105 on 
RabGDI are shown by an arrow. Modified from Rak et al.[295] 
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Because the role of the CBR in the presented structure appears to be in directing the 
Ypt C-terminus to the isoprenoid binding site on domain II via the MEL, mutations in 
this region can alternatively be expected to directly affect the accomodation of the 
isoprenoid on domain II. The C-termini of Rab proteins are highly heterogenous with 
respect to sequence and in length (hypervariable region), and largely determine the 
targeting of Rab proteins to distinct subcellular compartments, as was mentioned 
before (Chapter 1-2).[89,90] It is therefore conceivable that these regions must be 
recognized by putative membrane bound receptors, which are involved in the 
extraction and removal process. On the part of RabGDI, biochemical experiments 
have led to the suggestion that the mobile effector is involved in this interaction.[59,309] 
Indeed, in the obtained structure both components are well exposed and are 
positioned in close proximity to each other, demonstrating in a figurative manner their 
mutual presentation to the (putative) receptor by RabGDI. This could additionally 
explain the effect of the above-mentioned CBR mutations on the ability of RabGDI to 
extract and deliver Rabs from and to membranes. In these cases, the C-terminus 
could be forced to adopt a conformation, that is only poorly recognizable by the 
receptors mediating Rab membrane insertion or removal, which could lead to the 
observed redistribution of the Rab proteins.  
In principle, the extended surface of RabGDI between the Rab-binding platform and 
the lipid binding site seems to be suitable for acceptance of Rab C-termini of varying 
length. However, these tails typically range from 20 to more than 40 amino acid 
residues (beside the low degree of sequence conservation) and one could therefore 
assume, that the precise mode of the interaction is different. Moreover, these 
interactions could account for the observed differences in affinities of RabGDI toward 
various Rab family members.[308,321]  
The geranylgeranyl group is anchored in a crooked conformation in a deep cavity, 
which shields the lipid from the bulk water molecules and is formed by hydrophobic 
residues of RabGDI domain II (Figure 3-32). This observation was largely surprising, 
since the cavity is apparently neither present in the structures of apo-αRabGDI[308,309] 
nor in the structure of the related REP-1 complexed to GGTase-II.[105] 
Superimposition of these structures with the obtained Ypt1:RabGDI complex 
structure indicated, that the pocket appears as a result of conformational shifts in 
domain II upon binding of Ypt1.[295] Still, the molecular details (as well as the driving 
force) leading to the formation of the lipid-binding cavity are presently unclear.  
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Furthermore, the identified isoprenoid binding site on domain II is in contradiction to a 
previous structural study of bovine α-RabGDI co-crystallized with a Cys(GG)-OMe 
ligand, which proposed a hydrophobic patch on domain I below the Rab-binding 
platform as the coordination site of the geranylgeranyl group.[322] Nevertheless, 
independent mutational studies seem to support the genuineness and functional 
importance of the lipid binding site identified in the Ypt1:RabGDI complex structure. 
For example, the Met140Ile/Gly141Ser yeast RabGDI mutant protein has been shown 
to be defective in Rab membrane loading and Rab membrane delivery.[319] Both 
residues are located at the bottom of the identified hydrophobic cavity (Figure 3-31), 
and a substitution of both residues can therefore be expected to influence the 
conformation of the lipid binding pocket and coordination of the Ypt1 isoprenoid. 
Moreover, inspection of the obtained structure revealed the critical importance of 
Lys145 in the formation of the lipid-binding site by keeping two helices of domain II 
separated from each other. Mutation of this residue to alanine dramatically decreased 
the ability of RabGDI to extract Ypt1 from membranes.[295] Very recently, the structure 
of the monoprenylated Rab7:REP-1 complex was solved to 2.2 Å resolution and 
could confirm the location of the isoprenoid harbouring cavity on domain II†††.[324] 
The available space in the lipid-binding cavity is limited, precluding the simultaneous 
binding of two isoprenoids to this site (Figure 3-32). The search for a alternative site 
capable of accomodating the second geranylgeranyl group revealed a hydrophobic 
surface groove in close vicinity to the identified cavity on domain II as the most likely 
candidate site (Figure 3-32). The 1.4 Å resolution structure of doubly prenylated Ypt1 
complexed to RabGDI can be expected to resolve this issue. This complex was 
prepared in a similar manner by means of EPL, and the obtained structure is 
currently under investigation (see Figure 3-35A).  
In the structure of the mono-prenylated Ypt1:yRabGDI complex, the C-terminal 
α-carboxyl group of Ypt1 appears to point toward the domain II of RabGDI. One 
could hypothesize that binding of the isoprenoid group in the hydrophobic cavity 
effectively restricts the conformational freedom of the C-terminal cysteine residue, 
which is supported by the presence of interpretable electron density for this residue. 
In such a case, bulky C-terminal substituents (e.g. -NH-(CH2)2-NH-Dans) would clash 
                                                 
††† This complex was generated by preparative in vitro prenylation of the Rab7 protein containing a 
single cysteine mutant.[313,323] A similar approach could not be applied to the preparative production of 
Rab:RabGDI complexes due to experimental difficulties associated with the exchange of REP-1 for 
RabGDI following the prenylation reaction. 
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with residues of RabGDI domain II, which could explain the observed inability of 
RabGDI to interact with Rab proteins modified in such a way. On the other hand, the 
available space seems to be sufficient for accommodation of a sterically much less 
demanding methylester. Modeling studies of short prenylated peptides bound to the 
RabGDI domain II seem to support this notion (see Figure 3-33).  
 
 
 
Figure 3-33: Model showing the interaction of the peptide Cys-Cys(GG)-NH-(CH2)2-NH-Dans with 
RabGDI domain II (grey ribbon representation). The peptide (atomic colors) is superimposed with the 
geranylgeranyl lipid (green) identified in the crystal structure. Binding of the isoprenoid group in the 
hydrophobic cavity brings the C-terminal α-carboxyl group in close contact with residues of RabGDI. 
This results in sterical conflicts between bulky substituents linked to the C-terminus of Rab proteins 
and RabGDI domain II.  
 
 
The structure also provides a plausible explanation for the GDP-dissociation 
inhibitory effect of RabGDI exerted on Rab proteins. This seems due to a stabilization 
of the switch I and II regions in a closed conformation upon interaction with the 
Rab-binding platform of RabGDI.[295] The stiffness of this conformation compared to 
the flexibility of switch I and II regions in the structures of uncomplexed Rab proteins 
(e.g. [78]) can be expected to effectively hinder the nucleotide release from Rabs. This 
is illustrated by numerous mostly polar interactions formed between conserved 
residues present in the Rab-binding platform (and partially in the CBR) and the 
switch I and II regions (Figure 3-34). Especially the interaction between the side 
chain guanidino group of RabGDI Arg248 and the backbone carbonyl oxygen of the 
highly conserved Ypt Asp63 seems to indirectly enhance the binding of GDP via a 
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network of interactions. For example, the Asp63 sidechain carboxyl group is in 
hydrogen bond distance to one of four water molecules, which are ligands of the 
Mg2+ ion. On the other side the Mg2+ ion is coordinating to the β-phosphate group of 
GDP. Thus it seems likely that the Arg248/Ypt63 interaction stabilizes the coordination 
of the Mg2+ ion and consequentially decreases the extent of GDP release.  
Comparison of the present Ypt1:RabGDI structure with the GppNHp (a enzymatically 
non-hydrolyzable analog of GTP) bound Ypt7 structure revealed, that the switch 
regions in both structures adopt different conformations.[295] The GTP-bound 
conformation possibly gives rise to clashes between the switch regions and the Rab-
binding platform, which explains the observed preference of RabGDI for GDP bound 
Rabs. 
 
 
 
 
Figure 3-34: Interactions between the switch I and II regions of Ypt (grey, right side) and the Rab-
binding platform of RabGDI (red, left side). Residues involved in this interaction are shown in stick 
representation in atomic colors. Hydrogen bonds are indicated by dashed lines. See text for 
description. Reproduced from Rak et al.[295] 
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In conclusion, the developed semi-synthetic strategy was shown to be suitable for the 
generation of homogenously prenylated Rabs in preparative amounts (i.e. several 
milligram). The quality of the prepared complexes and of the obtained structural data 
substantiate the potency and versatility of the EPL strategy as an important 
alternative to established classical techniques. Needless to say, that the utility of 
such a strategy for structural studies is not restricted to prenylated Rabs. For 
example, in a recent report a very similar strategy was envisaged, in order to study 
the effects of C-terminal phosphorylation on the structure (1.8 Å resolution) and 
oligomerization behaviour of the SMAD-2 transcription factor.[325] 
 
3.5. Other semi-synthetic complexes intended for crystallographic 
analysis 
 
The general applicability of the EPL strategy for the semi-synthesis of prenylated Rab 
proteins could be further demonstrated by the generation of a variety of other 
complexes. For example double prenylated Ypt1∆3-CC(GG)C(GG) in complex with 
yeast RabGDI was prepared in a total amount of 16 mg. The obtained complex was 
of excellent purity and was crystallized by Dr. Alexey Rak, Department of Physical 
Biochemistry, MPI-Dortmund (Figure 3-35A). X-Ray diffraction data of these crystals 
were collected to 1.4 Å resolution. The preliminary structural analysis of the obtained 
data thus far did not reveal a well-defined electron density for the second conjugated 
isoprenoid group indicating that it is rather flexible and does not have a clearly 
specified position on the RabGDI surface. This appears logical, since two very 
strongly bound isoprenoids could possibly not be transferred into the lipid bilayer 
during Rab membrane delivery. Further structural analysis will be needed in order to 
clarify the localization of the second geranylgeranyl residue. 
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Figure 3-35: A) SDS-PAGE gel and MALDI-MS analysis of Ypt1∆3-CC(GG)C(GG):yRabGDI complex. 
In the SDS-PAGE experiment the complex was loaded on lane 1. yRabGDI (lane 2) and 
1-203Ypt1∆3-MESNA thioester (lane 3) are shown for comparison. The calculated molecular weights of 
1-203Ypt1∆3-CC(GG)C(GG) and yRabGDI are 23861 Da and 51401 Da, respectively. The red star 
marks the signal corresponding to the doubly charged yRabGDI ion (RabGDI+2H)2+. The inset shows 
the MALDI-MS spectrum of 1-203Ypt1∆3-MESNA thioester (Mcalc = 23076 Da). B) SDS-PAGE gel and 
MALDI-MS analysis of the complex between Rab7∆2-CC(GG) C205S and bovine RabGDI-1. The 
calculated molecular weights of 2-205Rab7∆2-CC(GG) C205S and RabGDI-1 are 23660 Da and 
50595 Da, respectively. 
 
Other examples of protein complexes prepared by the outlined EPL strategy include 
the mammalian single prenylated Rab7:RabGDI-1 complex (Figure 3-35B), the yeast 
single prenylated Ypt1:MRS6p complex (Figure 3-36A), and the yeast single 
prenylated Ypt1:MRS6p:GGTase-II  complex (Figure 3-36B). Although these 
complexes could not be crystallized so far, their preparation was straightforward 
using the elaborated protocols. In all cases the desired product was formed as could 
be inferred from mass spectroscopic experiments and the complexes appeared to be 
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of high purity. Thus taken together, the EPL semi-synthesis approach is generally 
applicable to a variety of Rab proteins and different peptides. 
 
 
 
Figure 3-36: A) SDS-PAGE gel and MALDI-MS analysis of Ypt1∆2-CC(GG):MRS6p complex. In the 
SDS-PAGE experiment the complex was loaded on lane 1. MRS6p (lane 2) and Ypt1∆2-MESNA 
thioester (lane 3) are shown for comparison. The calculated molecular weights of 1-204Ypt1∆2-CC(GG) 
and MRS6p are 23486 Da and 67545 Da, respectively. B) SDS-PAGE gel and MALDI-MS analysis of  
Ypt1∆2-CC(GG):MRS6p:yGGTase-II. 1-204Ypt1∆2-CC(GG) (Mcalc = 23486 Da), GGTase-II α-subunit 
(Mcalc = 35440 Da), GGTase-II β-subunit (Mcalc = 36860 Da), MRS6p (Mcalc = 67545 Da).  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. Summary and 
Conclusions 
 
 
 
 
 
 
 
“An expert is a man who has made all the mistakes which can be made, 
 in a narrow field.” 
 
Niels Bohr 
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4. Summary and Conclusions 
Native chemical ligation (NCL) and the related technique, expressed protein ligation 
(EPL), have been extremely useful for the synthesis of various proteins in the past. In 
particular the concept of EPL elegantly demonstrates the usefulness of combining 
the fields of chemistry and biology in order to address complex physiological and 
biochemical questions.  
The present study aimed at adapting the EPL methodology to the semi-synthesis of 
prenylated Rab proteins, which exert many important functions during vesicular 
transport in eukaryotic cells. To this end, short prenylated peptides, which were 
chemically synthesized by our collaborators from Prof. Waldmann´s lab at the 
MPI-Dortmund, were coupled site-specifically to the C-terminus of truncated Rab 
proteins. During this work some interesting and thus far unknown aspects of this 
reaction were observed. First, the EPL reaction with prenylated peptides was found 
to be strictly dependent on the presence of certain detergents. Although the role of 
these detergents in the ligation reaction remains elusive, one could hypothesize that 
they function as micellar catalysts. The micellar reaction media could prove useful in 
the future for the synthesis and solubilization of very hydrophobic polypeptide 
segments such as integral membrane protein domains. Secondly, Rab thioesters 
terminating in glutamine or asparagine seem to be prone for side reactions, which 
probably involves the formation of cyclic imides. These side products were found to 
be capable of reacting with prenylated peptides under the typical reaction conditions.    
These studies also clearly point out the restrictions of applying chemical methods to 
the solution of biological problems, namely the necessity to work in an aqueous 
environment in order to preserve the solubility and the functional state of biological 
macromolecules. Although the remarkable solvent incompatibility of the Rab proteins 
and the examined prenylated peptides could be overcome, the employed conditions 
gave rise to protein denaturation. Eventually, the prenylated Rab proteins could be 
‘revived’ by an in vitro refolding approach. The obtained semi-synthetic proteins were 
complexed to specific interacting proteins, such as RabGDI, REP-1 and GGTase-II, 
indicating, that the Rab proteins indeed adopted the correctly folded state. This was 
further confirmed by GGTase-II activity assays. 
Using this approach, for the first time both single prenylated Rab proteins, 
representing the genuine intermediates of the GGTase-II catalyzed prenylation 
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reaction, were obtained. The interaction of these single prenylated Rabs with 
GGTase-II was further explored by taking advantage of fluorophores incorporated 
into the synthetic prenylated peptides. Different fluorophore attachment sites were 
tested in order to study the consequences of the fluorophore incorporation on the 
function of the GTPase. The obtained results could show, that the single prenylated 
proteins are tightly bound to GGTase-II with dissociation constants (Kd) in the lower 
nanomolar range. Furthermore, the determined dissociation rate constants (koff) of 
this interaction revealed, that dissociation of the single prenylated intermediate is not 
required for Rab double prenylation.  
The introduced fluorophore could also be utilized for the time-resolved monitoring of 
the prenylation reaction. Under conditions permitting only a single enzymatic 
turnover, the rates of the second prenyltransfer reaction were determined, which are 
in excellent agreement with values recently reported in the literature. The obtained 
data indicate, that the tighter bound single prenylated reaction intermediate is also 
faster converted to the double prenylated product. This suggests, that GGTase-II has 
evolved an active site that clearly prefers one of the two possible reaction 
intermediates for the second round of prenylation (namely that intermediate, which is 
prenylated on the C-terminal cysteine residue). Together with the results of previous 
studies these observations imply, that at least in the case of Rab7 the majority of 
proteins proceed to double prenylation by acquiring the first isoprenoid on the 
C-terminal cysteine residue followed by geranylgeranylation of the upstream cysteine 
residue.  
Another major aim of the present study was to provide multi-milligramm amounts of 
semi-synthetic and prenylated Rab proteins in complex with various interacting 
proteins for crystallographic studies. Out of six complexes tested in crystallization 
trials, two were crystallized and the structures were determined to very high 
resolutions (1.5 Å and 1.4 Å). The obtained structures of the single and doubly 
prenylated Ypt1:RabGDI complexes permit important insights into the mechanisms of 
RabGDI mediated Rab membrane extraction and delivery and a plausible 
explanation for the GDP dissocation inhibitory effect.  
In conclusion, the developed EPL approach seems to be perfectly suited for the 
generation of homogenously prenylated Rab proteins in large quantities (i.e. several 
milligram). The outlined protocols are easy to perfom and should permit the 
production of functionalized Rab proteins on a routine basis.  
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The proteins generated in such a manner were demonstrated to be valuable tools for 
biochemical and biophysical studies.  
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4. Summary and Conclusions (german) 
 
Native chemical ligation (NCL) und die verwandte Technik Expressed Protein 
Ligation (EPL) haben sich in der Vergangenheit als äußerst nützlich für die Synthese 
von verschiedenen Proteinen erwiesen. Insbesondere das Konzept der EPL 
demonstriert auf elegante Weise die Nützlichkeit einer Kombination von Chemie und 
Biologie, um komplexe biochemische und physiologische Fragestellungen zu 
beantworten.  
Das Ziel der vorliegende Arbeit war es, die EPL Methode für die Semisynthese von 
prenylierten Rab Proteinen zu entwickeln. Rab GTPasen haben eine 
Schlüsselfunktion bei der Kontrolle des intrazellulären vesikulären Transportes in 
eukaryotischen Zellen. Die posttranslationale Modifikation von zwei Cysteinen mit je 
einem hydrophoben Lipid (Prenylierung) im C-terminalen Bereich der Rab Proteine 
wird von der Geranylgeranyltransferase II (GGTase-II) katalysiert und ist essentiell, 
um den Rab Proteinen die Ausübung ihrer Funktionen zu ermöglichen. 
Im Rahmen dieser Arbeit wurden kurze, geranylgeranylierte (C20 isoprenoide 
Verbindung) Peptide mit Hilfe der EPL spezifisch C-terminal an verkürzte Rab Protein 
α-Thioester gekuppelt. Bei diesen Studien wurden einige interessante (und bis dato 
nicht beschriebene) Aspekte dieser Reaktion beobachtet. Es konnte festgestellt 
werden, dass die erfolgreiche Synthese der lipidierten Peptid-Protein-Konjugate die 
Verwendung bestimmter Additive, insbesondere von Detergenzien, vorraussetzte. 
Obwohl die Wirkungsweise der Detergenzien bei der Reaktion nicht eindeutig 
bestimmt werden konnte, lässt sich dennoch vermuten, dass sie als mizellare 
Katalysatoren fungieren. Diese Erkenntnisse könnten sich in Zukunft bei der 
Synthese von anderen (integralen) Membranproteinen als nützlich erweisen. 
Desweiteren konnte beobachtet werden, dass Rab Protein α-Thioester zu 
Nebenreaktionen neigen, wenn es sich bei der C-terminal aktivierten Aminosäure um 
Asparagin oder Glutamin handelt. Diese Nebenreaktionen führen zur Zyklisierung der 
C-terminalen Aminosäure. Die entstandenen Imide konnten interessanterweise unter 
den typischen EPL Bedingungen mit prenylierten Peptiden umgesetzt werden. 
Die durchgeführten Untersuchungen zeigen auch die Einschränkungen einer 
Anwendung chemischer Methoden auf die Beantwortung biologischer 
Fragestellungen auf,  insbesondere die Notwendigkeit in wässrigen Lösungsmittel zu 
arbeiten, um die Löslichkeit und den funktionalen Zustand biologischer 
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Makromoleküle zu erhalten. Obwohl die bemerkenswerte Lösungsmittel-
inkompatibilität der Rab Protein α-Thioester und der untersuchten prenylierten 
Peptide gelöst werden konnte, so führten die angewandten Bedingungen dennoch 
zur Denaturierung der Proteine. Die Rückfaltung der lipidierten Rab Proteine konnte 
in dieser Studie zum ersten Mal erfolgreich durchgeführt werden. Die erhaltenen 
semisynthetischen Rab Proteine sind biologisch aktiv und konnten mit bekannten 
Interaktionspartnern komplexiert werden (z.B. mit RabGDI, REP-1, GGTase-II). 
Das ausgearbeitete Verfahren erlaubte zum ersten Mal die Generierung von einfach 
prenylierten Rab Proteinen, die als Intermediate bei der GGTase-II katalysierten 
Prenylierungsreaktion kurzzeitig auftreten. Mit Hilfe der Fluoreszenzspektroskopie 
und Fluoreszenzmarkern, die in die synthetischen Peptide eingebaut wurden, konnte 
die Wechselwirkung dieser Intermediate mit der GGTase-II detailiert studiert werden. 
Die erhaltenen Dissoziationskonstanten (die diese Interaktion beschreiben) konnten 
zeigen, dass die Intermediate sehr fest an die GGTase-II gebunden sind. Mit Hilfe 
der ebenfalls bestimmten Geschwindigkeitskonstanten der Dissoziation konnte 
darüberhinaus ein Modell entwickelt werden, nach dem eine Dissoziation der einfach 
prenylierten Intermediate im Verlauf der Rab Doppelprenylierungsreaktion nicht 
zwangsläufig stattfinden muss. 
Die eingeführten Fluoreszenzmarker ermöglichten ferner die Zeit aufgelöste 
Beobachtung des enzymatischen Umsatzes der einfach prenylierten Intermediate 
zum doppelprenylierten Produkt. Die Daten lassen darauf schliessen, dass die 
GGTase-II eine klare Präferenz für eines der zwei möglichen Reaktionsintermediate 
aufweist. Zumindest im Falle von Rab7 scheint demnach die Mehrheit der Proteine 
zuerst C-terminal prenyliert zu werden, gefolgt von der Modifizierung des intern 
lokalisierten Cysteins.      
Ein weiteres Ziel der vorliegenden Arbeit war die Generierung von prenylierten Rab 
Proteinen im Multimilligramm Maßstab für kristallografische Studien. Auch in diesem 
Fall wurden die semisynthetischen Rab Proteine an Interaktionspartner komplexiert. 
Sechs Komplexe konnten im präparativen Maßstab gewonnen werden, von denen 
zwei erfolgreich kristallisiert werden konnten. Die Strukturen der einfach und doppelt 
prenylierten Rab:RabGDI Komplexe wurden mit hoher Auflösung bestimmt und 
ermöglichten erstmals einen strukturellen Einblick in die Funktion von RabGDI. 
Zusammenfassend kann gesagt werden, dass das entwickelte EPL Verfahren ideal 
erscheint, um homogen prenylierte Rab Proteine in preparativer Menge zu erhalten. 
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Die ausgearbeiteten Protokolle sind leicht durchführbar und sollten die routinemäßige 
Produktion von unterschiedlich funktionalisierten Rab Proteinen ermöglichen. Die 
Nützlichkeit solcher Proteine konnte in dieser Arbeit mit Hilfe von biochemischen und 
biophysikalischen Studien demonstriert werden. 
     
  
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Materials and Methods 
 
 
 
 
 
“Science is a collection of successful recipes.” 
 
Paul Valery 
 
 
  
 
 5. Materials and Methods 90 
 
5. Materials and Methods 
5.1. Materials 
5.1.1. Chemicals 
 
All chemicals were purchased from the following companies with the highest purity 
available. 
Supplier Compound 
Applichem 
Darmstadt, Germany 
Acrylamid/Bisacrylamide (37.5:1, 30 %), methanol, 
GdmHCl, ammoniumsulfate 
Gerbu 
Gaiberg, Germany 
DTT, DTE, SDS, HEPES, EDTA, glycerol, 
isopropyl-β-D-thiogalactopyranoside (IPTG) 
Hampton Research, 
Laguna Niguel, CA, USA 
Detergent Screen Kit I-III 
JT Baker 
Deventer, NL 
Acetonitrile, ethanol, 2-propanol, acetone, urea, 
chloroform, dichloromethane, dipotassium 
hydrogenphosphate, potassium dihydrogen-
phosphate, potassium hydroxide, hydrochloric acid, 
sodium chloride, potassium chloride 
Merck 
Darmstadt, Germany 
Ammonium persulfate (APS), sodium hydroxide 
Pharma Waldhof 
Düsseldorf, Germany 
GDP 
Roth 
Karlsruhe, Germany 
 
CHAPS, CTAB, TRIS 
Serva 
Heidelberg, Germany 
TEMED, bromphenol blue, Coomassie Brilliant 
Blue R250, Triton X-100, ampicillin (Amp), DMSO, 
β-mercaptoethanol 
Sigma  
Taufkirchen, Germany 
GGPP, sinapinic acid, ethidium bromide, BSA, 
trifluoracetic acid, LDAO, agarose, 
phenylmethylsulfonylfluoride (PMSF),  
 
Table 5-1: Chemicals 
5.1.2. Peptides 
 
All peptides used in this study were synthesised by members of Prof. Waldmann´s 
group at the Max-Planck-Institute of Molecular Physiology, Dortmund and the 
University of Dortmund. Table 5-2 and the accompanying figure summarize a 
selection of peptides, which were coupled to truncated Rab/Ypt proteins by means of 
EPL. Synthetic procedures and analytical data can be found in the indicated 
references. The peptides were typically provided as a pale yellowish oil. Stock 
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solutions of 20-40 mM were usually prepared in dichloromethane/methanol (1:10) 
solvent systems and were stored at -80°C under an atmosphere of argon.[221]  
 
 
 
No. Name Core structure R1 R2 R3 Source and References 
1 H-Cys(StBu)-Lys(Dans)-Ser-
Cys(GG)-Ser-Cys(GG)-OMe 
A Dans GG GG Dr. Ines Heinemann [219,293] 
2 H-Cys(StBu)-Lys(Dans)-Ser-
Cys(StBu)-Ser-Cys(GG)-OMe 
A Dans StBu GG Dr. Ines Heinemann [219,292] 
3 H-Cys(StBu)-Lys(Dans)-Ser-
Cys(GG)-Ser-Cys(StBu)-OMe 
A Dans GG StBu Dr. Ines Heinemann [219,293] 
4 H-Cys(StBu)-Lys(NBD)-Ser-
Cys(StBu)-Ser-Cys(GG)-OMe 
A NBD StBu GG Dr. Ines Heinemann [219] 
5 H-Cys(StBu)-Glu-Ser-Cys(GG)-Ser-
Cys(GG)-NH(CH2)2NH-Dans 
B Dans GG GG Anja Watzke [220,294] 
6 H-Cys(StBu)-Glu-Ser-Cys(GG)-Ser-
Cys(GDans)-OMe 
C - GG GDans Dr. Lucas Brunsveld [294] 
7 H-Cys(StBu)-Cys(GG)-OH D - GG - Anja Watzke [295,220] 
8 H-Cys(StBu)-Cys(GG)-NH(CH2)2NH-
Dans 
E Dans GG - Anja Watzke [220] 
9 H-Cys(StBu)-Cys(GG)-Cys(GG)-OH F - GG GG Anja Watzke [220] 
10 H-Cys(StBu)-Lys(Dans)-Cys(GG)-
OMe 
G Dans GG StBu Dr. Ines Heinemann [219] 
11 H-Cys-Lys(Dans)-Cys(GG)-OMe G Dans GG H Dr. Ines Heinemann [219] 
Table 5-2: Peptides used in this study 
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The peptide H-Cys-Lys-Lys-Arg-Arg-Leu-Lys-Cys(GG)-NH-(CH2)2-NH-Dans was 
synthesised by Daniel Gottlieb, Department of Chemical Biology, MPI-Dortmund. 
5.1.3. General instrumentation 
 
Protein purification was usually carried out on a Pharmacia Biotech GradiFrac system 
(Uppsala, Sweden). Centrifugation was performed using Eppendorf 5415C/D bench-
top centrifuges (Eppendorf, Cologne, Germany)  or a Avanti J20-XP Centrifuge from 
Beckman Coulter (Palo Alto, CA, USA). For preparative ultracentrifugation a 
Beckmann Optima L-70K centrifuge was used. SDS-PAGE was performed using the 
Biorad Mini-Protean II system. Measurements of the pH were performed using a 
pH-meter 761 from Calimatic Knick (Berlin, Germany). Deionized water (ddH2O) was 
produced by an apparatus from Millipore (Eschborn, Germany). Dialysis tubes 
(MWCO: 14 kDa) were from Schleicher and Schuell (Dassel, Germany). For 
concentration of proteins various devices from Millipore (Eschborn, Germany) were 
used. Representations of crystal structures were created with the program Pymol 
(www.pymol.org). Modeling studies were carried out by Dr. Kirill Alexandrov, MPI-
Dortmund using the ICM 3.0.25j software package (Molsoft, USA).  
5.1.4. Frequently used buffers and growth media 
 
LB medium      SDS-PAGE running buffer (10x) 
 
0.5 % (w/v)   yeast extract    0.25 M Tris-HCl    
1 % (w/v) tryptone    2 M glycine 
1 % (w/v) NaCl     1 % (w/v) SDS 
 
 
SDS-PAGE stacking gel buffer   SDS-PAGE resolving gel buffer 
 
0.5 M  Tris-HCl, pH 6.8   1.5 M   Tris-HCl, pH 8.8 
0.4 % (w/v) SDS      0.4 % (w/v) SDS 
 
 
SDS-PAGE loading buffer (2x)   Coomassie stain solution 
 
100 mM  Tris-HCl, pH 6.8   10 % (v/v)  acetic acid 
4 % (w/v) SDS     40 % (v/v)  methanol 
20 % (v/v) glycerol    0.1 % (w/v) Coomassie Brilliant Blue  
200 mM  DTT       R250 
0.05 % (w/v) bromophenol blue 
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Coomassie destain solution   TAE buffer (1x)   
 
10 % (v/v) acetic acid    40 mM  Tris acetate   
50 % (v/v) methanol    2 mM   EDTA 
        
PBS (10x)      DNA loading buffer (5x)   
 
80 g  NaCl     10 %   Ficoll 400 
2 g    KCl     50 mM  Na2EDTA, pH 8.0 
14.4 g   Na2HPO4 ⋅ 2 H2O   0.05 % (w/v)  SDS 
2.4 g  KH2PO4    0.15 % (w/v) bromphenol blue  
ddH2O to 1 l      0.15 % (w/v) xylene cyanol (optional) 
 
5.2. Analytical methods 
5.2.1. MALDI-TOF-mass spectrometry 
 
MALDI spectra were recorded on a Voyager-DE Pro Biospectrometry workstation 
from Applied Biosystems (Weiterstadt, Germany). Protein samples were desalted 
using small GF spin columns (Quiagen, Hilden, Germany) and mixed with an equal 
volume of sample matrix (10 mg/ml sinapinic acid and 0.1 % (v/v) TFA in 
water/acetonitril (1:1)). The mixture was quickly spotted on a MALDI sample plate, 
air-dried and spectra were measured with the following device settings: acceleration 
voltage = 25 kV, grid voltage = 93 %, extraction delay time = 750 ns and guide 
wire = 0.3 %. The laser intensity was manually adjusted during the measurements in 
order to obtain optimal signal to noise ratios. Calibrations were carried out using a 
protein mixture of defined molecular mass (Sigma). Spectra recording and data 
evaluation was performed using the supplied Voyager software package. The 
accuracy of the method for proteins within the molecular weight range of 20-30 kDa is 
ca. ± 20 Da (Dr. Heino Prinz, MPI-Dortmund, personal communication). 
5.2.2. LC-MS measurements 
 
LC-MS analysis was performed on an Agilent 1100 series chromatography system 
(Hewlett Packard) equipped with an LCQ electrospray mass spectrometer (Finnigan, 
San Jose, USA) using Jupiter C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-size) 
from Phenomenex (Aschaffenburg, Germany). For LC-separations a gradient of 
buffer B (0.1 % formic acid in acetonitrile) in buffer A (0.1 % formic acid in water) with 
a constant flow-rate of 1 ml/min was employed. Upon sample injection, a ratio of 
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20 % buffer B was kept constant for 2 min. Elution was achieved using a linear 
gradient of 20-50 % buffer B in buffer A over 13 min followed by a steep gradient 
(50-90 % buffer B) over 3 min. The column was extensively flushed for at least 
10 min with 95 % buffer B. Data evaluation and deconvolution was carried out using 
the Xcalibur software package. The accuracy of the method for proteins within the 
molecular weight range of 20 kDa is ca. ± 1-2 Da (Dr. Heino Prinz, MPI-Dortmund, 
personal communication). 
5.2.3. Analytical reversed-phase (RP) and gel filtration (GF) HPLC 
 
Analytical reversed-phase (RP) and gel filtration (GF) chromatography were 
performed on a Waters 600 chromatography instrument equipped with a Waters 
2475 fluorescence detector and a Waters 2487 absorbance detector (Waters, Milford, 
MA, USA). Jupiter C4 columns (5 µm, 15 x 0.46 cm, 300 Å pore-size) from 
Phenomenex (Aschaffenburg, Germany) were used for RP separations, whereas 
Biosep-SEC-2000 columns (60 x 0.78 cm, separation range 1-300 kDa, 
Phenomenex) were used for gel filtration. Chromatographic GF separations were 
performed using 50 mM sodium phosphate, pH 7.0, 50 mM NaCl, 2 mM DTE, 10 µM 
GDP, 1 mM MgCl2 as a running buffer at a flow rate of 0.7 ml/min. Separation was 
usually complete within 30 min. 
For RP separations the following gradient of buffer B (0.1 % TFA in acetonitrile) in 
buffer A (0.1 % TFA in water) at a flow rate of 1 ml/min was used: The column was 
equilibrated with 5 % buffer B in buffer A. Upon sample injection this ratio was kept 
isocratic for 2 min followed by a linear gradient (5-30 % buffer B) over another 2 min. 
Individual components eluted upon a linear gradient (30-70 % buffer B) over 10 min 
and another isocratic phase (70 % buffer B) of 4 min. Afterwards the column was 
flushed for at least 10 min with 100 % buffer B in order to elute hydrophobic 
compounds (e.g. geranylgeranylated peptides). Data analysis was carried out using 
the Millenium software package provided by Waters. 
5.2.4. Denaturing SDS-PAGE 
 
Typically 15 % SDS-PAGE gels were used for the analysis of Rab proteins (MW of 
ca. 24 kDa). The corresponding volumes of the individual components as indicated 
by Table 5-2 were mixed and the resolving gel was cast using a Biorad Multi-casting 
apparatus (10 gels). After the resolving gel was polymerized, a stacking gel mix was 
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prepared and cast atop the resolving gel. Protein samples were prepared by adding 
an equal amount of SDS-PAGE sample buffer (2x) and heated for 5 min at 95° C. 
Gels were run at ca. 10 V/cm until the bromphenol blue front had entered the buffer 
solution. Fluorescently labeled proteins were visualized by exposing the unstained 
SDS-PAGE gel to UV light. The proteins were subsequently stained using a solution 
of Coomassie brilliant blue. 
 
Type of gel 
(%) 
Acrylamide/ 
bisacrylamide 
(29:1, 30 %) 
ddH2O 
Resolving 
gel buffer 
Stacking 
gel buffer 
TEMED 
10 % 
APS 
Resolving gel, 70 ml 
10 % 23.5 ml 27.6 ml 17.1 ml --- 29 µl 700 µl
15 % 34.2 ml 15.7 ml 17.1 ml --- 29 µl 700 µl
Stacking gel, 30 ml 
5 % 4.9 ml 20 ml --- 3.7 ml 300 µl 29 µl 
Table 5-3: Pipeting scheme for SDS-PAGE gels. TEMED = N,N,N´,N´-tetramethylethylendiamine; 
APS = ammoniumpersulfate.  
 
5.2.5. Western-Blot 
 
The unstained SDS-PAGE gel was equilibrated together with 6 sheets of Gel-blotting 
paper and a nitrocellulose membrane (both from Schleicher & Schuell, Dassel, 
Germany) of approximately the same size for 10 min in transfer buffer 
(250 mM Tris-HCl, pH 8.3, 192 mM glycine, 1.3 mM SDS, 10 % methanol (v/v)). A 
blot sandwich was constructed in the following order: cathode - 3 sheets of 
Whatmann filter paper - gel - nitrocellulose membrane - 3 sheets of Whatmann filter 
paper - anode. The transfer was carried out for 1-2 h at a current of 1.5 mA/cm2 in a 
Semi-Phor semi-dry blot apparatus from Hoefer Scientific Instruments (San 
Francisco, CA, USA). The efficiency of transfer can be judged by staining the gel with 
Coomassie Blue or by staining of the membrane with Ponceau S solution (5 g/l 
Ponceau S in acetic acid/ddH2O (1:100)). The membrane was briefly washed 3 times 
with PBS and subsequently blocked for at least 1 h with hot blocking solution (5 % 
non-fat dry milk, 0.1 % Tween-20 in PBS). The membrane was briefly washed 
3 times with wash solution (0.06 % non-fat dry milk, 0.01 % Tween-20 in PBS) and 
incubated with the primary antibody solution for at least 1 h. Polyclonal primary and 
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secondary antibody sera were typically diluted 1:1000 to 1:10000 with 0.6 % non-fat 
dry milk, 0.01 % Tween-20 in PBS prior to use. The membrane was briefly washed 
3 times with wash solution and incubated with the horseradish peroxidase coupled 
secondary antibody for 1 h. The membrane was rinsed 3 times with wash solution 
and 3 times with PBS. Horseradish peroxidase conjugates were detected using the 
ECL kit (Amersham, UK).  
5.3. Biochemical methods 
5.3.1. Expression and purification of GGTase-II, REP-1, RabGDI, 
MRS6p and Rab7wt 
 
All proteins were kindly prepared and provided by Anca Niculae (Department of 
Physical Biochemistry, MPI-Dortmund). Mammalian RabGGTase was purified from 
E. coli BL21(DE3) codon plus cells expressing a hexahistidine-GST tagged  
α-subunit and an untagged β-subunit.[313] Briefly, following cell growth, induction and 
lysis of the cells, GGTase-II was purified from crude homogenate using Ni-NTA 
Sepharose columns (Pharmacia). The affinity tag was removed by digestion with TEV 
protease. A second Ni-NTA chromatography was performed in order to remove the 
cleaved-off hexahistidine tag, uncleaved GGTase-II and TEV protease. For 
production of GST tagged GGTase-II (see chapter 4.3.3.), the eluate of the first 
Ni-NTA column was further purified by anion-exchange chromatography 
(Poros 50 HQ columns, Perseptive Biosystems, Framingham, MA, USA) and dialysis. 
REP-1 was purified from insect cells infected with recombinant baculovirus[326] or 
from recombinant yeast S. cerevisiae.[327] The protein was purified by a combination 
of Ni-NTA affinity and gel filtration chromatography. Rab7 and RabGDI wild-type 
proteins were expressed and purified in a similar manner.[114,328] Expression and 
Purification of MRS6p is described elsewhere.[205] 
5.3.2. Expression and purification of Rab/Ypt-thioester proteins 
 
All semi-synthetic Rab and Ypt proteins either in complex with REP-1, MRS6p, 
RabGDI or uncomplexed were prepared according to the devised protocols shown 
below (4.3.2. and 4.3.3.). Although the method is generally applicable, certain critical 
points are discussed in more detail in chapter 3. 
The plasmid coding for the desired Rab/Ypt-Intein-CBD construct was transformed 
into E.coli BL21(DE3) cells using electroporation and transformants were selected on 
 5. Materials and Methods 97 
 
ampicillin (50 mg/l) agar plates. A single colony was inoculated into 5 ml of LB 
medium containing 125 mg/l Ampicillin and the culture was grown overnight at 37° C. 
This pre-culture was used to seed 2 l of fresh LB medium (containing 125 mg/l 
ampicillin) and the culture was incubated at 37° C until the absorbance at 600 nm 
(OD600) reached 0.5 - 0.7. The cells were cooled down on ice, IPTG was added to a 
final concentration of 0.5 mM and overnight (or 10 - 12 h) induction was performed at 
20° C. The cells were cooled down to 4° C and all subsequent steps were performed 
at this temperature. Cells were harvested by centrifugation (5000 g, 20 min, 4° C) 
and washed once in PBS. Cells could be stored frozen at -80° C at this point. Levels 
of protein expression before and after induction were determined by SDS-PAGE. The 
bacterial pellet was resuspended in lysis buffer (25 mM sodium phosphate, pH 7.5, 
0.5 M NaCl, 1 mM PMSF, 2 mM MgCl2, 10 µM GDP) and the cells were lysed by 
passing them twice through a Microfluidizer. A fresh portion of 0.5 mM PMSF and 
Triton X-100 (1 % final concentration) were added. The lysate was cleared by 
ultracentrifugation (30000 g, 40 min, 4° C) and the supernatant was transferred to 
Falcon tubes. An appropriate amount of chitin beads, equilibrated with lysis buffer 
containing 1 % Triton X-100 was added and the mixture was incubated for 2 h on a 
rotating wheel at 4° C (1 ml of beads can bind about 2 mg of fusion-protein. The total 
amount of expressed fusion protein can be estimated by SDS-PAGE and Coomassie 
Blue staining). The suspension was centrifuged (2500 g, 5 min, 4° C) and the 
supernatant removed. To remove unspecifically bound material beads were washed 
4 times with lysis buffer containing 1 % Triton X-100 followed by 4 times washing with 
buffer without the detergent. Cleavage of the fusion protein was induced by adding 
powdered MESNA to the beads suspension to a concentration of 0.5 M and 
overnight incubation at room temperature. The supernatant was collected by 
centrifugation and was passed over a gel filtration column equilibrated with ligation 
buffer (20 mM sodium phosphate, pH 7.5, 100 µM MgCl2, 100 µM GDP). The pooled 
fractions were concentrated to at least 10 mg/ml and shock frozen using liquid 
nitrogen. The proteins could be stored at -80° C for at least 2 years without loss of 
ligation efficiency. Yields typically ranged from 20 - 40 mg of Rab/Ypt protein 
thioester per liter of bacterial culture.  
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5.3.3. Ligation of geranylgeranylated peptides to Rab/Ypt-thioester 
 
500 µl of Rab/Ypt-thioester protein (typically 20 mg/ml, ca. 500 nmol) in ligation buffer 
was supplemented with 50 mM CTAB and 125 mM MESNA (final concentrations). 
The reaction is initiated by adding 3.5 - 5 µmol of the peptide in a suitable solvent 
(peptide stock solutions of 30 mM were often prepared in methanol/dichloromethane 
solvent systems). The reaction mixture was incubated overnight at 37° C with 
vigorous agitation. Under these reaction conditions ligated and unligated proteins 
usually precipitated together with excessive peptide. The reaction mixture was 
centrifuged and the supernatant removed. The pellet was washed once with 1 ml 
methanol, 4 times with 1 ml methylenchloride, 4 times with 1 ml methanol and 4 times 
with 1 ml Milli-Q (ddH2O) water at room temperature in order to resolubilize 
contaminating peptide and unligated protein. The progress of the purification was 
monitored by SDS-PAGE. The precipitate was dissolved in denaturation buffer 
(100 mM Tris-HCl, pH 8.0, 6 M GdmHCl, 100 mM DTE, 1 % CHAPS, 1 mM EDTA) to 
a final protein concentration of 0.5 - 1.0 mg/ml and incubated overnight at 4° C with 
slight agitation. The solution can be stored (indefinitely) at this point at -80° C. The 
solution was cleared from any insoluble material by centrifugation or by filtration 
through 0.2 µm celluloseacetate filter units (Schleicher & Schuell). The protein was 
then renatured by diluting it at least 25 fold drop-wise into refolding buffer 
(50 mM Hepes pH 7.5, 2.5 mM DTE, 2 mM MgCl2, 100 µM GDP, 1 % CHAPS, 
400 mM arginine-HCl, 400 mM trehalose, 1 mM PMSF, 1 mM EDTA) with gentle 
stirring at room temperature. Typically 10 portions of the denatured sample were 
stepwise added to the refolding vessel within 2 h (pulse renaturation). The mixture 
was incubated 30 min further at room temperature followed by a centrifugation step 
(30000 g, 30 min, 4° C) in order to remove aggregated material. An aliquot of the 
supernatant was TCA precipitated and analyzed by SDS-PAGE. The total amount of 
soluble protein was judged by the intensity of Coomassie blue stained protein bands.     
 
Variant A: Complex formation with RabGDI, MRS6p, REP-1 and  GGTase-II 
 
An equimolar amount of the respective protein was added and the solution was 
incubated for 1 h on ice. The mixture was dialyzed against two 5 l changes of dialysis 
buffer (25 mM Hepes, pH 7.5, 2 mM MgCl2, 10 µM GDP, 2.5 mM DTE, 
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100 mM (NH4)2SO4, 10 % glycerol, 1 mM PMSF, 1 mM EDTA). The dialyzed material 
was concentrated to a protein concentration of 1 - 4 mg/ml using size-exclusion 
concentrators (MWCO: 30 kDa) and subsequently centrifuged (13000g, 5 min, 4° C) 
to remove insoluble material. The supernatant was loaded on a 26/60 Superdex-200 
gel filtration column (Pharmacia) equilibrated with gel filtration buffer (25 mM Hepes, 
pH 7.5, 2 mM MgCl2, 10 µM GDP, 5 mM DTE, 100 mM Na2SO4, 1 mM EDTA, 
10 % glycerol, for protein complexes intended for crystallization glycerol was 
omitted). The peak fractions containing the desired complex (SDS-PAGE) were 
pooled, concentrated to approximately 10 mg/ml and stored frozen at -80° C in 
multiple aliquots. The typical recovery yield ranged from 10 - 50 % with respect to 
starting Rab/Ypt-thioester. 
 
Variant B: Purification of uncomplexed, ligated protein  
 
The mixture was concentrated to ca. 10 - 20 ml using stirred size exclusion 
concentrators (MWCO: 10 kDa, Amicon). The retained protein solution was diluted 
with 100 ml of 25 mM Hepes, pH 7.5, 2 mM MgCl2, 10 µM GDP, 2.5 mM DTE, 
100 mM (NH4)2SO4, 0.6 % CHAPS and concentrated to a protein concentration of ca. 
1 mg/ml. The mixture was loaded on a PD-10 desalting column (Amersham) 
equilibrated with the same buffer. The eluted protein was concentrated to 3 - 5 mg/ml 
using size-exclusion spin concentrators (MWCO: 10 kDa, Millipore) and shock-frozen 
in liquid nitrogen in multiple aliquots. The protein was stored at -80° C. 
5.3.4. In vitro protein prenylation 
 
Variant A : Preparative production of doubly prenylated Rab7:REP-1 complex 
 
Rab7wt (3.6 mg, 150nmol) was mixed with 11.1 mg REP-1 (150 nmol) in an 
Eppendorf tube. 22.5 mg of mammalian GST-GGTase-II (150 nmol) were mixed with 
1 µmol of geranylgeranylpyrophosphate (GGPP) in another tube. The buffer of both 
tubes was adjusted to 0.3 % CHAPS, 10 µM GDP, and approximately 40 mM Hepes, 
pH 7.2, 5 mM DTE, 3 mM MgCl2 and 50 mM NaCl. Both tubes were incubated on ice 
for 2 min followed by mixing of the contents in order to initiate the prenylation 
reaction. Usually incubation at 37° C for 10 min was sufficient for > 90 % double 
prenylation of Rab7. The reaction mixture was diluted to 6 ml with in vitro prenylation 
 5. Materials and Methods 100 
 
buffer (40 mM Hepes, pH 7.2, 50 mM NaCl, 5 mM DTE, 2.5 % CHAPS, 3 mM MgCl2, 
10 µM GDP) and passed three times over a glutathion Sepharose 4B column 
(Pharmacia, 6 ml bed volume) equilibrated with the same buffer. The flow-through 
was loaded on a 26/60 Superdex 200 GF column (Pharmacia) equilibrated with in 
vitro prenylation buffer without CHAPS. Fractions containing binary Rab7:REP-1 
complex were pooled, concentrated to approximately 20 mg/ml and stored at -80° C 
in multiple aliquots. 
 
Variant B: Incorporation [3H]-geranylgeranyl groups  into Rab proteins. 
 
Standard reaction mixtures contained the following components in a final volume of 
50 µl: 50 mM Hepes, pH 7.2, 5 mM MgCl2, 1 mM DTT, 3 mM Nonidet P-40, 5.5 µM 
[3H]-Geranylgeranylpyrophosphate (14000 cpm/pmol) and the indicated amounts of 
Rab:REP complex and GGTase-II. The reaction mixtures were incubated at room 
temperature for 20 min. The reaction was subsequently quenched by addition of 2 ml 
of 10% HCl in 90% ethanol. After 30 min, the reaction mixture was filtered through 
glass fiber filters (Whatman). The filters were rinsed twice with 96 % ethanol, 
immersed in scintillation liquid and counted for 3H.  
5.4. Biophysical methods 
 
Fluorescence measurements were performed either with an Aminco SLM 8100 
spectrofluorometer (Aminco, Silver Spring, MD, USA) or a Spex Fluoromax-3 
spectrofluorometer (Jobin Yvon, Edison, NJ, USA). Measurements were carried out 
in 1 ml quartz cuvettes (Hellma) with continuous stirring and thermostated at 25° C 
unless otherwise indicated. Stopped-flow measurements were performed on a 
Applied Photophysics SX.18MV-R apparatus (Surrey, UK). 
5.4.1. Fluorescence titrations – determination of Kd 
 
Steady-state fluorescence measurements for monitoring interactions between semi-
synthetic Rab7:REP-1 complexes with GGTase-II were followed in 50 mM Hepes, 
pH 7.2, 50 mM NaCl and 5 mM DTE. Typically the dansyl labeled Rab7:REP-1 
complex was placed in a cuvette in 1 ml of buffer to give a final concentration of ca. 
100 - 200 nM and incubated for 5 min at 25° C. The excitation and emission 
monochromators were set to 280 nm and 495 nm, respectively. Small aliquots of 
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GGTase-II (typically 10-20 nM at each step) were then added to the cuvette, until the 
fluorescence signal was saturated or showed a continuous linear increase. The 
change in fluorescence was plotted as a function of the total GGTase-II concentration 
and corrected for unspecific fluorescence. The data was fitted to the following 
equation using GraFit 4.0 (Erithacus software): 
 
where Y is the observed fluorescence after each step of titrator addition, Ymin is the 
initial value at [L]0 = 0, Ymax is the final value at saturation, [L]0 is the total 
(cumulative) concentration of GGTase-II, [P]0 is the Rab7:REP-1 complex 
concentration, and Kd is the equilibrium constant, which is to be determined (see 
appendix 7.1.1. for a derivation of this equation and further explanation). 
5.4.2. Transient kinetics – determination of koff 
 
For determination of koff, the dansyl labeled semisynthetic Rab7:REP-1 complex 
(100 nM) was incubated with an equal amount of GGTase-II (100 nM) at 25° C in 
1 ml of buffer (50 mM Hepes, pH 7.2, 50 mM NaCl and 5 mM DTE) for 5 min. The 
excitation wavelenght was set to 280 nm, while data were collected at 495 nm. The 
fluorescently labeled complex was displaced from GGTase-II by addition of an at 
least 10 fold excess of double prenylated wtRab7:REP-1 complex (1 - 1.5 µM final 
concentration, prepared as described in chapter 5.3.4.). Under certain conditions 
(which were applied in this case, see appendix), the obtained displacement curve 
could be fitted to a single exponential equation: 
tkoffAeYY −+= 0  
 
where Y is the observed fluorescence, Y0 is the fluorescence at t = ∞, A is the signal 
amplitude, t is the time, and k is the rate constant, which equals koff for dissociation of 
the semi-synthetic Rab7:REP-1 complex from GGtase-II. Data analysis was carried 
out using GraFit 4.0 (Erithacus software). 
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5.4.3. Monitoring the prenylation reaction 
 
The prenylation of the semisynthetic Rab7 proteins was analysed using a Spex 
Fluoromax-3 spectrofluorometer (Jobin Yvon, Edison, NJ, USA) for long-term 
measurements, whereas a stopped-flow apparatus (Applied Photophysics, Surrey, 
UK) was used for examining the fast events occurring upon start of the reaction. 
 
Long-term measurements 
 
Typically, 50-100 nM of dansyl labeled semisynthetic Rab7:REP-1 complex was 
mixed with an equal amount of GGTase-II in a cuvette, containing 1 ml of buffer 
(50 mM Hepes, pH 7.2, 50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 100 µM GDP). 
Following a 5 min incubation at 25° C permitting temperature equilibration, the 
reaction was started by adding geranylgeranyl-pyrophosphate to a final concentration 
of approximately 10 µM. Excitation and emission monochromators were adjusted to 
280 nm and 510 nm, respectively. The data were fitted to a double exponential 
equation using GraFit 4.0 (Erithacus software): 
 
tktk eAeAYY 21 210
−− ++=  
 
where Y is the observed fluorescence, Y0 is the fluorescence at t = ∞, A1 and A2 are 
the signal amplitudes, t is the time, and k1 and k2 are the rate constants. 
 
Stopped-flow measurements 
 
Dansyl labeled Rab7:REP-1:GGTase-II ternary complex (ca. 200 nM) in 
50 mM Hepes, pH 7.2; 50 mM NaCl, 5 mM DTE, 2 mM MgCl2, 100 µM GDP was 
rapidly mixed in the stopped-flow apparatus with an equal volume of 
geranylgeranylpyrophosphate in the same buffer (concentration ranged from 200 nM 
to 20 µM). Excitation was at 280 nm, while fluorescene was recorded through a 
420 nm cut-off filter. Mixing and measuring chamber were thermostated at 25° C 
using a wather bath. Typically, curves of 5 independent experiments were averaged 
using the software package provided by Applied Photophysics.   
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5.5. Molecular biology 
5.5.1. Plasmids and bacterial strains 
 
Plasmids 
All plasmids were from the Department of Physical Biochemistry, MPI-Dortmund. 
Plasmid Name Insert 
Resistance/
Selection 
marker 
Application and 
References 
pTYB1_Rab7∆6 canine Rab7∆6 Amp 
pTYB1_Ypt7∆7 yeast Ypt7∆7 Amp 
pTWIN1_Ypt1∆2 yeast Ypt1∆2 Amp 
pTWIN1_Rab7∆2 canine Rab7∆2 Amp 
pTWIN2_Ypt1∆3 yeast Ypt1∆3 Amp 
pTWIN1_Rab5a∆4 human Rab5a∆4 Amp 
pTWIN1_Rab5a∆5 human Rab5a∆5 Amp 
Expression of insert-
intein-CBD fusion 
proteins and generation 
of C-terminal 
α-thioesters.[199,292] 
pGATEVmod_RabGGTase α rat 
RabGGTase α Amp 
pET30_RabGGTase β rat 
RabGGTase β Kan 
Coexpression of the 
RabGGTase subunits 
with a His6-GST tag on 
the N-terminus of the 
α-subunit. The tag can 
be cleaved off by TEV 
protease.[313] 
pET19mod_Rab7 canine Rab7wt Amp 
pET19mod_yGDI yeast GDI Amp 
* pFastBac_GDI-1 bovine GDI-1  Amp 
Expression of the 
corresponding protein 
N-terminally modified 
with a hexahistidine tag. 
The tag can be cleaved 
off by TEV protease. 
[114,295,328]  
** pYES2_REP-1 rat REP-1 
Amp 
URA3 
Expression of REP-1 
C-terminally modified 
with a hexahistidine tag 
in yeast.[327] 
* pVL_REP-1 rat REP-1 Amp 
pET30a_MRS6 yeast MRS6p Kan 
Expression of REP-1 or 
MRS6p modified with a 
hexahistidine tag. 
[205,326] 
 
Table 5-4: Plasmids used in this work. Empty pTWIN and pTYB vectors were obtained from New 
England Biolabs (Beverly, MA, USA). Typically expression was performed using one of the E. coli 
strains listed below. * Expression in SF21 cells upon infection with recombinant baculovirus. 
** Expression in yeast S. cerevisiae strain BJ5459. Amp = ampicillin, CBD = chitin-binding domain, 
Kan = kanamycin, URA3 = auxotrophic selection on minimal media without uracil. 
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Bacterial strains 
 
XL1 Blue     recA1, endA1, gyrA96, thi-1, hsdR17, supE44,  
(Stratagene)    relA1, lac [F´, proAB, lacIqZ∆M15, Tn10 (Tetr)] 
 
BL21(DE3)     F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3)  
(Novagen)    
 
BL21(DE3) Codon Plus RIL  F-, ompT, lon, hsdS (rB-, mB-), dcm, gal, λ(DE3), 
(Stratagene)    endA, Hte [argU ileY leuW Camr] 
   
5.5.2. Preparation and transformation of competent cells 
 
1 l of LB medium was inoculated with 1 ml of an overnight-grown culture of the 
desired E.coli strain. Cells possessing antibiotic resistance genes (e.g. BL21(DE3) 
codon plus RIL) were grown in the presence of the corresponding antibiotic. The 
culture was incubated at 37° C on a shaker, until the OD600 reached 0.5 (ca. 3 - 4 h). 
The culture was cooled on ice for 20 min, transferred to sterile centrifugation vessels 
and centrifuged for 10 min at 4° C and 2000 g. The supernatant was decanted. 
 
Variant A.: Transformation by Electroporation[329] 
 
The bacterial cell pellet was gently (!) resuspended in 5 ml of ice-cold sterile GYT 
(0.125 % (w/v) yeast extract, 0.25 % (w/v) tryptone, 10 % (v/v) glycerol) and 
recentrifuged as described above. Cells were resuspended in a final volume of 1 ml 
GYT, dispensed in 50 µl aliquots, shock frozen in liquid nitrogen and stored at -80° C. 
For transformation, approximately 1 ng of DNA was added to the thawed cell 
suspension in a chilled cuvette. Electrotransformation was carried out by applying a 
high voltage pulse using a E.coli Pulser from Biorad (conditions: 25 µF, 200 Ω, 
2.5 kV). 1 ml of LB medium was added to the cell suspension and the culture was 
grown at 37° C for 1 h. Transformed Cells were selected on agar plates containing 
the corresponding antibiotics. 
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Variant B.: Transformation using CaCl2 
 
The pellet was gently resuspended in 20 ml of  ice-cold sterile 100 mM CaCl2 solution 
and incubated on ice for 30 min. The cells were centrifuged at 2000 g for 5 min at 
4° C and were resuspended in 1 - 5 ml of TFBII buffer (10 mM MOPS, pH 7.0, 
75 mM CaCl2, 10 mM NaCl, 15 % glycerol). Aliquots of 50 - 100 µl were shock frozen 
in liquid nitrogen and stored frozen at -80° C. 
For transformation, cells were thawed rapidly and approximately 1 ng of the desired 
plasmid DNA was added. The mixture was incubated on ice for 30 min without 
shaking. Cells were heat-shocked at 42° C for 60 sec and immediately cooled on ice 
for 2 min. 1 ml of LB medium was added to the tube and the culture was incubated at 
37° C for 1 h, before recombinants were selected on agar plates supplemented with 
the corresponding antibiotics. 
5.5.3. Purification of DNA 
 
DNA fragments 
 
DNA fragments produced by PCR amplification or restriction enzyme digestion were 
purified by preparative agarose gel electrophoresis. The band of interest was excised 
and extracted from the gel using a gel extraction kit from Quiagen or PQLab 
according to the instructions of the manufacturer.  
 
Agarose gel electrophoresis 
 
Depending on the size of the DNA fragment, the agarose concentration was between 
0.8 and 1.2 % (w/v). The required amount of agarose was solubilized by heating in 
TAE buffer. Ethidium bromide was added to a final concentration of 0.01 % (w/v), the 
gel was poured into the gel casting equipment and allowed to polymerize. Samples 
were prepared in DNA loading buffer and the gels were run horizontally at 10 V/cm 
immersed in TAE-buffer until fragment separation was complete. A 1 kb DNA ladder 
(GibcoBRL) was used as a molecular weight standard. 
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Preparation of Plasmid DNA 
 
Plasmid DNA was prepared using the plasmid mini-prep kit (Quiagen or PQLab) as 
follows: A single bacterial colony was used to seed 2 ml of LB medium containing the 
appropriate antibiotic(s). The culture was grown overnight (10 - 12 h) at 37° C. Cells 
were harvested by centrifugation (3000 g, 5 min) and lysed by alkaline/SDS 
treatment. The precipitate (chromosomal DNA, lipids, proteins) was removed by 
centrifugation and the supernatant was loaded on a silica spin column. Following 
washing, the plasmid DNA was eluted using sterile TAE buffer or deionized water. 
  
Ethanol precipitation 
 
The salt concentration of the DNA sample was adjusted to 250 - 300 mM sodium 
acetate, pH 5.5 and DNA was precipitated by adding ethanol (96 %) to a final 
concentration of ca. 70 % followed by a 30 min incubation at room temperature. After 
centrifugation (10000 g, 10 min, RT) and removal of the supernatant, the precipitate 
was washed once with 70 % ethanol and dried under vacuum. 
5.5.4. PCR 
 
Preparative PCR 
 
Typically, a 50 µl reaction mixture comprised 1 - 5 ng of template (plasmid) DNA, 
0.5 - 1.0 µM of upstream and downstream primers, 200 µM of each dNTP, 2-3 units 
of Expand High Fidelity Polymerase mix (Roche Diagnostics, Mannheim, Germany) 
and the corresponding reaction buffer and salts. A Biorad PE 9700 thermocycler from 
Applied Biosystems (Weiterstadt, Germany) was used for temperature control and 
cycling. Denaturation was for 1 min at 96° C, annealing for 1 min at 50 - 62° C 
depending on primer length and GC content, and extension was for 2 - 4 min 
(depending on the length of the amplicon). In general, 15 - 20 cycles were sufficient 
for efficient amplification.   
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Colony PCR screen 
 
Colonies were picked and resuspended in 20 µl of sterile ddH2O in a PCR test tube 
using sterile eppendorf tips. 6 µl of this suspension were mixed with 6 µl of PCR mix 
(containing 400 µM of each dNTP, 5 pmol of each primer, 1 unit of Taq polymerase 
(Sigma, Taufkirchen, Germany) in Taq buffer (2x)). The PCR reactions were carried 
out under the following conditions: Cells were disrupted by heating the PCR tubes for 
3 min at 96° C followed by 25 cycles of denaturation for 30 sec at 96° C, annealing 
for 30 sec at 50 - 62° C, and primer extension for 40 sec at 72° C. The PCR products 
were analyzed by agarose gel electrophoresis.  
An aliquot (1 µl) of the initially obtained cell suspension was plated on agar plates 
containing the corresponding antibiotics. 
 
DNA Sequencing  
 
For DNA sequencing of the cloned fragments the BigDyeDesoxy terminator cycle 
sequencing kit and a ABI Prism 373XL machine (Applied Biosystems, Weiterstadt, 
Germany) was used. The sequencing reactions contained 0.5 - 1 µg plasmid DNA, 
3 pmol of the corresponding primers, and 8 µl BigDye termination mix in a final 
volume of 20 µl. 25 cycles were performed with the following parameters: 
Denaturation for 30 sec at 96 °C (for the first cycle 1 min), annealing for 1 min at 
50° C, and primer extension for 4 min at 60° C. The DNA was ethanol precipitated 
(see above), washed twice with 70 % ethanol, dried, and analyzed by the in house 
sequencing facility.  
5.5.5. Restriction enzyme digestion 
 
Restriction enzyme digests of DNA fragments were performed as recommended by 
the manufacturer. The reaction was stopped by addition of DNA loading buffer. 
Fragments produced by restriction enzyme digestion were separated using agarose 
gel electrophoresis. 
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5.5.6. Ligation 
 
For ligation 1-10 ƒmol of linear plasmid DNA was mixed with a 10 fold molar excess 
of fragment DNA. Ligation was performed in T4 DNA ligase buffer in a volume of 
12.5 µl, using 0.2 units of T4 DNA ligase (Roche Diagnostics, Mannheim, Germany) 
for 12 - 16 h at 16° C. 
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7. Appendices 
 
 
 
 
 
“The reasonable man adapts himself to the world. 
The unreasonable man persists in trying to adapt the world to himself. 
Therefore all progress depends on the unreasonable man.” 
 
George Bernard Shaw 
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7. Appendices 
7.1. Derivation of equations 
7.1.1. Reversible second-order reactions - equilibrium titrations[330] 
 
This mode of binding can be described by the following equations, where [P]G, [L]G 
and [PL]G are the equilibrium concentrations of protein (P), ligand (L) and 
protein:ligand complex (PL) and Kd is the corresponding equilibrium constant, which 
is to be determined. 
 
 
 
 
With 
 
 
this will result in  
 
 
where [P]0 and [L]0 are the total concentrations (free and bound) of protein and 
ligand, respectively. 
 
This can be rearranged to  
 
 
The solutions of this quadratic equation are : 
 
 
(eq. 1) 
 
 
Simple calculations can demonstrate, that only the substraction will produce 
meaningful results (because [PL]G can only be ≤ [P]0). The fractional completion of 
the binding reaction (r) can be observed using spectroscopic techniques and 
corresponds to : 
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Where Y is some experimental observable, such as fluorescence intensity, 
anisotropy or absorbance. This equation is only valid if the quantity Y is (a) a linear 
function of the fractional completion of the reaction and (b) does not depend on other 
reactions. This equation can be rearranged to: 
 
 
(eq. 2) 
 
 
Replacing [PL]G in eq. 2 with eq. 1 will result in : 
 
 
(eq. 3) 
 
 
 
 
Figure 7-1: Simulation of titration curves. In all cases 100 nM of protein (= [P0]) was titrated with 
increasing concentrations of Ligand. Ymax and Ymin were set to 10 an zero, respectively. The behaviour 
of the curves depends on the ratio of Kd to [P0]. Kd = 1 nM (⎯⎯), Kd = 50 nM (- - - -) and 
Kd = 400 nM (-⋅⋅-⋅⋅-). 
 
[ ] [ ]0
minmax
min P
YY
PLYY G
−+=  
[ ]( ) [ ] [ ] [ ] [ ]( ) [ ] [ ]{ } [ ]0minmax0020000min0 24 PYYLPPLKPLKYLY dd −−++−+++=  
  133 
 
7.1.2. Kinetics of ligand dissociation (e.g. [331]) 
 
The dissociation rate constant (k1) of a labeled ligand (L*) from its complex (PL*) can 
be determined by displacing it with an unlabeled ligand (L). The simplest model that 
describes both reactions is: 
 
 
The dissappearance of PL* can then be described by  
 
(eq. 4)   [ ] [ ][ ] [ ]*1*1* PLkPLkdtPLd −= − . 
 
It can be assumed, that in the present case both the labeled and the unlabeled ligand 
interact with the protein in a similar manner and that the rate constants describing the 
association and dissociation reaction are in the same order of magnitude (i.e. k1 ~ k2 
and k-1 ~ k-2). If one chooses the concentrations of the components such that 
[L*] ∼ [P] << [L], then the association rate of the competitor L with the free protein is 
significantly faster than the reassociation of the labeled ligand L* 
(i.e. k-2[L] >> k-1[L*][P]), which would make the dissociation of PL* quasi irreversible. 
Under such conditions the concentration of free (unbound) protein P is very low 
([P] Æ 0) and the term k-1[L*][P] is negligible. This will give 
 
(eq. 5, 6) [ ] [ ]*1* PLkdtPLd −=        and upon integration [ ] [ ] tkePLPL 10** −= . 
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